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Tuberculosis! (TB)! caused! by! bacteria! of! the! Mycobacterium- tuberculosis! complex!
(MTBC)! is! the! second! major! cause! of! death! from! an! infectious! disease! worldwide.!
Recent! advances! in! DNA! sequencing! are! leading! to! the! ability! to! generate! whole!
genome! information!of! clinical! isolates!of!MTBC.! The!objectives!of! this!work! include!
developing! bioinformatic! tools! for! processing! and!making! accessible!MTBC! genomic!
data,!as!well!as! the! identification!of! informative!genetic!markers,!both!strainOspecific!
and! associated!with! drug! resistance! (DR),! to! barcode!MTBC! isolates! in! research! and!
clinical!settings.!
SpolPred! software! was! developed! to! accurately! predict! the! spoligotype! from! raw!
sequence! reads,! and!used! to! bridge! the! gap!between! classical! genotyping! and!highO
throughput! sequencing.! A! genome! variation! discovery! pipeline!was! implemented! to!
derive! genomic! polymorphisms! from! MTBC! raw! sequence! data.! This! pipeline! was!
applied! to!>1,500!publicly! available! isolates! and! the! characterised! genomic! variation!
hosted!in!PolyTB,!a!webObased!tool!where!genetic!variants!can!be!investigated!using!a!
genome! browser,! a! world! map! showing! their! global! allele! distribution,! and! an!
additional!phylogenetic!view.!An!extensive!repertoire!of!strainOspecific!mutations!was!
identified,! of! which! a! subset! was! proposed! to! accurately! discriminate! known!MTBC!
circulating! strains.! A! curated! list! of!DR! associated!mutations!was! compiled! from! the!
literature!and!their!diagnostic!accuracy!for!predicting!phenotypic!resistance!assessed.!




Whole! genome! sequencing! (WGS)! promises! to! be! transformative! for! the! practice! of!
clinical!microbiology,!and!the!rapidly!falling!cost!and!turnaround!time!mean!that!this!
will! become! a! viable! technology! in! clinical! settings.! In! this! new! paradigm,! the!
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Tuberculosis! (TB)! is! the! second! most! common! cause! of! death! from! an! infectious!
disease!worldwide,!only!behind! the!Human! Immunodeficiency!Virus! (HIV)!pandemic.!
According! to! the! latest! estimates! from! the!World!Health!Organisation! (WHO),! there!
were!8.6!million!new!TB!cases!in!2012!and!1.3!million!deaths,!of!which!0.3!million!were!
HIVOassociated! (World! Health! Organization! 2013).! The! majority! of! cases! in! 2012!
occurred! in! Asia! (58%)! and! Africa! (27%),! while! smaller! proportions! occurred! in! the!
Eastern! Mediterranean! region! (8%),! Europe! (4%)! and! the! American! continent! (3%)!
(Figure!1.1).!SouthOEast!Asia!and!Africa!accounted!for!75%!of!the!total!TB!deaths.!India!









due! to! the! availability! of! efficacious! treatments,! TB! remains! a! major! global! health!
threat.!The!emergence!and!spread!of!DR!forms!of!TB!further!hinders!TB!control.!The!
WHO! classifies! TB! resistant! to! isoniazid! (INH)! and! rifampicin! (RMP),! the! two! most!
effective! firstOline! antiOTB! drugs,! as! multi! drugOresistant! TB! (MDROTB).! Globally,! it! is!
estimated!that!3.6%!of!new!TB!cases!and!20.2%!of!previously!treated!cases!are!MDRO
TB! (World! Health!Organization! 2013).! The! highest! levels! of!MDROTB! are! reported! in!
Eastern!Europe!and!Central!Asia! (Figure!1.2).!Globally,!only!a! small!proportion!of!TB!
cases! are! tested! for! MDR! (5%! of! newly! diagnosed! TB! cases! and! 9%! of! previously!






Diagnosis!and! treatment!of!MDROTB!cases! remain!major!challenges!and!are! far! from!
being! fully! achieved! (Dheda! et- al.! 2014).! Extensively! drugOresistance! (XDR)! strains,!
presumably! emerged! from! MDROTB! strains! and! resistant! to! the! secondOline! drugs!
fluoroquinolones!(FLQ)!and!aminoglycosides!(AMI),!have!been!reported!in!92!countries!
and,! on! average,! 9.6%! of!MDROTB! cases! are! estimated! to! be! XDROTB! (World! Health!
Organization!2013).!
Human! TB! is! caused! by! bacteria! belonging! to! the!M.- tuberculosis! complex! (MTBC),!
which! is! transmitted! between! people! by! inhalation! of! aerosol! droplets! that! contain!
bacteria.!TB!cases!are!predominantly!caused!by!M.-tuberculosis-(Mtb)-followed!by!M.-
bovis!and!M.-africanum,!with!occasional!cases!of!infection!with!M.-caprae,!M.-microti,!
M.- pinnipedii,-M.- orygis! and!M.- canettii! reported.! They! are! slow! growing,! lipid! rich!
gramOpositive!actinomycetes!with!characteristic!cell!walls!conferring!natural!resistance!
to!many! antibiotics! (Brennan! 2003).!Members! of! the!MTBC! are! indistinguishable! in!
their!16SrRNA!and!rpoB-genes,! interOstrain!recombination!has!not!been!reported!and!
they!have!approximately!the!same!genome!length!(GarciaOBetancur!et-al.!2011).!




of! inflammatory! cells! in! the! lungs! (Cooper! et- al.! 2011).!Mtb- is! disseminated! to! the!
lymph! nodes,!where! dendritic! cells! present! bacterial! antigens! to! naïve! TOcells!which!
then!differentiate!into!antigenOspecific!effector!T!cells!(Chackerian!et-al.!2002;!Wolf!et-
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al.! 2008).!Migration!of! these!T! cells! to! the! infected! lung! stimulates! the! formation!of!











Although! this! immune! response! controls! the! infection,!Mtb! can! survive! within! the!
macrophages!for!months!or!even!years! in!a!clinically!asymptomatic!state,!referred!to!











rate! of! MTBC! bacteria.! The! rapid! molecular! test! Xpert®! MTB/RIF! is! considered! an!
important! breakthrough! in! TB! diagnosis.! This! automated! PCR! assay! can! detect! both!
MTBC! bacteria! and! RMP! resistance,! normally! within! two! hours! and! directly! from!
sputum!(Steingart!et-al.!2014).!Xpert®!MTB/RIF!was!endorsed!by!the!WHO!in!2010!and!
has!been! rapidly!adopted!by! countries! since! then! (World!Health!Organization!2013).!
Detection! of! resistance! to! antiOTB! drugs! relies! on! bacterial! culture! followed! by! drug!
susceptibility!testing!(DST).!Solid!culture!generally!takes!between!four!to!eight!weeks!
and! liquid!culture,! though!more! rapid! than!solid!culture,! still! takes!days!and! is!more!
prone!to!contamination!(Dheda!et-al.!2014).!
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Laboratory! confirmation! of! TB! and! DR! is! crucial! to! ensure! that! infected! people! are!
given!appropriate!treatment.!Standard!regimens!of!firstOline!drugs!applied!for!several!
months!can!usually!eliminate!TB.!FirstOline!therapies!consist!of!combinations!of!drugs!
that!were!discovered!more! than!50! years! ago!and! include! INH! (discovered! in!1952),!
RMP! (1966),! ethambutol! (EMB)! (1961),! pyrazinamide! (PZA)! (1952)! and! streptomycin!
(STR)! (1943).!MDROTB! strains!are!now!widespread! throughout! the!world,!with!about!
half! a!million! cases! reported! in!2012! (World!Health!Organization!2013).! To! cure! this!
type!of!strains,!a!switch!to!second!line!treatments!is!advised.!Resistance!to!additional!
drugs! such! as! EMB! or! STR! further! compromises! treatment! (Tahaoğlu! et- al.! 2001;!
Migliori!et-al.!2009).!SecondOline!regimens!use!drugs!such!as!FLQ!and!AMI,!which!are!
associated! with! multiple! toxic! effects! and! lower! cure! rates.! These! treatments! have!
longer!duration!(for!example,!current!regimens!recommended!by!WHO!entail!at!least!
20!months)!and!may!cost!up!to!100!times!more!than!firstOline!treatments!(Dheda!et-al.!









against!human!TB.!However,! its!efficacy! is! variable!between!human!populations!and!
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confers! low!protection! in! developing! countries! (Fine! 1995).!More! than!12! candidate!
vaccines! are! currently! being! tested! in! clinical! trials! (Ottenhoff! &! Kaufmann! 2012).!
These! vaccines! aim! to! induce! T! cellOmediated! immunity! required! to! prevent!
progression! into! active! pulmonary! disease! (NunesOAlves! et- al.! 2014)! and! ultimately!




There! is! an!urgent!need! for!better! treatments! and! vaccines,!which! in! turn! require! a!
deeper! understanding! of! the! biology! of!Mtb.! Knowledge! of! the! genomic! variability!














improve! the! understanding! of! Mtb- biology! and! aid! in! the! development! of! new!
therapies! and! vaccines.! The! circular! genome! comprising! 4.4!million! base! pairs! (Mb)!
was! found! to! contain! around! 4,000! genes! and! to! have! a! relatively! high! GC! content!
(65%).! Unlike! other! bacterial! genomes,!Mtb- genome! was! found! to! encode! a! large!
number!of!enzymes!involved!in!lipid!metabolism.!Some!of!these!produce!multiple!and!
diverse! lipophilic! molecules,! ranging! from! simple! fatty! acids! to! veryOlongOchain! and!
highly!complex!mycolic!acids,!the!predominant! lipid!component!of!the!mycobacterial!
cell! wall! (Brennan! 2003).! Other! enzymes! are! used! to! degrade! hostOcell! lipids,!
particularly!fatty!acids!and!cholesterol,!and!used!as!energy!sources!during!intracellular!
growth!and!persistence!(Ouellet!et-al.!2011).!Two!protein!families!(PE!and!PPE!genes)!
were! found! to! comprise! about! 10%! of! the! coding! potential! of! the! genome.! These!
proteins!have!a!repetitive!structure,!are!highly!polymorphic!and!their!function!remains!
largely! unknown.! Although! initially! suggested! to! be! involved! in! antigenic! variation,!
their!possible!function!as!variable!surface!antigens!and!their!role!in!immune!evasion!is!
still! an! area! of! active! research! (Copin! et- al.! 2014;! Comas! et- al.! 2010).! Since! its!
publication! in! 1998,! the! H37Rv! reference! genome! has! been! functionally! annotated!
with!information!from!the!scientific!literature!(Lew!et-al.!2011)!and!nowadays!contains!
a!total!of!4,018!protein!genes,!13!pseudogenes!and!80!RNA!loci.!
WholeOgenome! sequencing! (WGS)!of!multiple! strains! has! also! enabled!more! reliable!
reconstructions! of! the! phylogenetic! history! of! MTBC! (Comas! et- al.! 2013).! Both!
archaeological! findings! and! comparative! genome! analyses! conflict! with! a! zoonotic!
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origin!of!humanOadapted!TB.!According!to!the!zoonotic!hypothesis,!an!ancient!M.-bovis!
strain! could! have! been! transferred! from! cows! to! humans! during! animal!
domestications.!
A!new!scenario!of!the!evolutionary!history!of!MTBC!has!emerged.!There! is!mounting!





While! STB! strains! are! genetically! diverse! and! show! evidence! of! extensive!
recombination! and! horizontal! gene! transfer! (HGT),!MTBC! seems! to! have! arisen! as! a!
clonal! expansion! from!a! single! STB!progenitor! (Supply!et- al.! 2013),! and!displays! low!
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genetic! diversity! as! a! consequence! of! this! clonal! population! structure.! After! MTBC!
emerged!in!Africa,!it!spread!with!the!first!human!migrations!(Blouin!et-al.!2012;!Comas!
et- al.! 2013;! Supply! et- al.! 2013)! and! differentiated! into! six! major! global! lineages!
associated!with!a!restricted!geographical!area!(Gagneux!et-al.!2006).!
In! addition! to! the! study! of! macroevolutionary! episodes! of! TB,! WGS! has! also! been!
applied! to! investigate! the!microevolution! events! occurring!within! individual! patients!
and! between! different! patients! along! transmission! chains.! WGS! can! differentiate!
between!relapse!and!reOinfection!in!cases!of!recurrent!TB!with!greater!resolution!and!
accuracy! than! standard! fingerprinting! techniques! (RFLP! and! MIRUOVNTR)! (Bryant,!
Harris,! et- al.! 2013).! WGS! has! proved! to! be! successful! in! delineating! community!
outbreaks!of!TB,!inferring!chains!of!transmission!between!cases!and!identifying!superO
spreaders! (Gardy! et- al.! 2011;!Walker! et- al.! 2014;!Walker! et- al.! 2013;! Roetzer! et- al.!







year.! This! mutation! rate! is! 10Ofold! lower! than! that! of! methicillinOresistant!
Staphylococcus-aureus-(Nübel!et-al.!2010)!and!explains,! in!part,!the! limited!sequence!
diversity!of!MTBC!(Schürch!et-al.!2010).!The!substitution!rate!is!a!valuable!measure!as!
it! can! be! used! to! estimate! the! common! ancestor! originating! date! of! outbreakO
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circulating!strains!(Roetzer!et-al.!2013).!The!choice!of!a!minimum!number!of!SNPs!to!
establish! epidemiological! links! between! TB! infected! patients! has! been! more!
controversial.! The! recent! finding! that! the! genetic! diversity! accumulated! within! a!
patient! can! be! as! high! as! that! observed! between! patients! (PérezOLago! et- al.! 2014)!
poses!challenges!for!establishing!thresholds!and!inferring!transmission!events.!!




rely! on! antimicrobial! susceptibility! testing! and! bacterial! genotyping,!which!may! take!
several!months!to!be!accomplished!because!of!the!slow!growth!rate!of!MTBC.!In!this!





a! resistant! strain! (Clark! et- al.! 2013),! based! on! the! presence! of! phylogenetically!
informative!mutations.!However,!WGS!cannot!replace!phenotypic!susceptibility!testing!
for! all! antibiotics,! given! the! incomplete! understanding! of! the! genetic! causes! of!
resistance!(Sharon!J.!Peacock!2013)!of!some!of!them!(Bhuju!et-al.!2013;!Brossier!et-al.!
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Current! Illumina! sequencers,! e.g.! Illumina! Genome! Analyser! II! and! HiSeq2000,! can!
sequence!hundreds!of!bacterial!genomes!of!a!few!mega!bases!(Mb)!to!at!least!50Ofold!
coverage! in! a! single! run! (www.illumina.com).! Because! of! the! short! length! of!
sequencing!reads!(50O250!bp),!these!platforms!have!been!extensively!employed!in!reO
sequencing! projects,! i.e.! when! a! complete! genome! from! a! close! strain! or! species! is!







al.! 2010),! a! textObased! format! for! storing! both! the! nucleotide! sequence! and! its!
corresponding! quality! scores.! Quality! control! and! filtering! are! firstly! applied! to! raw!
reads! in! order! to! minimise! the! artefacts! arising! during! the! sequencing! reactions,!




reads! against! a! reference! genome,! a! requisite! stage! for! downstream! analyses.!With!





Some! implementations! incorporate! pairedOend! information,! i.e.! the! constraints!
imposed!by!mate!pairs!in!terms!of!distance!and!orientation,!to!resolve!read!mapping!
at! repetitive! regions! and! correct! for! alignment!errors.! Base!quality! in! reads!has! also!
been!exploited!by!programs!like!MAQ-(Li!et-al.!2008)!and!BWA! (Li!&!Durbin!2010)!to!
further! improve! alignment! accuracy.! These! programs! output! both! aligned! and!
unaligned! reads! in! Sequence! Alignment/Map! (SAM)! format! (H.! Li! et- al.- 2009),! a!
standardised!format!widely!supported!by!downstream!bioinformatic!tools!(e.g.!variant!
callers,! alignment! viewers).! SAM- and! BAM- files! (i.e.! the! compressed,! indexed! and!
binary! form)! contain! all! reads! initially! stored! in! FASTQ- file(s)! plus! their! mapping!
information,! including! their! position!with! respect! to! the! reference,!mapping! quality,!
pairOend! information,!etc.!The!development!and! improvement!of!efficient!shortOread!
alignment! algorithms! made! the! fast! processing! of! data! produced! by! SSTs! feasible!
which,! initially,! entailed!a!bottleneck! in! the!analysis!of! such!highOcoverage! sequence!
datasets.!
                @title and optional 
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target! sequence! not! assisted! by! the! comparison! to! previously! resolved! reference!
sequences.! It! follows! a! bottomOup! strategy! by!which! reads! are! grouped! into! contigs!
and!those!into!scaffolds!covering,!ideally,!the!whole!chromosome!length.!Despite!the!
limitations! initially! imposed!by!NGS!data,!high!coverage!currently!achieved!(e.g.!100x!
by! Illumina! HiSeq2000),! growing! read! lengths! (150! bp! by! Illumina! HiSeq2000)! and!
pairedOend! information! makes! it! feasible! to! obtain! relatively! low! fragmented!









are! likely! to!be! sequencing!errors! (Figure!1.6).! SNP!calling! tools! (Nielsen!et-al.! 2011)!
make! use! of! this! information! to! calculate! statistical! significance! and! filter! out! false!





Alignment! of! sequencing! reads! to! a! region! of! the!Mtb! reference! genome.! Reads! are! displayed! as!
rectangles! in!gray! if!matching! the! reference!sequence.!Mismatches!are!colourOcoded!by!nucleotide:!A!
green,!C!blue,!G!yellow!and!T!red.!A!mismatch! is!found!across!most!of!the!reads!centred! in!the!figure!
(probable!SNP).!Spurious!mismatches!are!likely!to!be!sequencing!errors.!




three! categories:! signatures! based! on! discordant! mapping! of! read! pairs,! signatures!
based!on!read!splitting!and!signatures!based!on!DOC!(Alkan!et-al.!2011).!SV!programs!
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novo! assembly! of! genomes! followed! by! subsequent! pairOwise! comparison! to! the!
reference! genome!will! become! the! standard!method!of! SV!detection.! This! approach!
has! not! been! reliable! to! resolve! all! genomic! regions,! especially! regions!with! repeats!
and! duplications,! due! to! limited! read! lengths! and! differences! in! coverage! between!
regions.! Nevertheless,! with! increasing! read! lengths! and! DOC! obtained! by! the! latest!
generation! of! sequencers! it! will! be! possible! to! produce! relatively! low! fragmented!
assemblies!from!bacterial!genomes!(Utturkar!et-al.!2014).!
1.5 Research+aims+and+objectives+




1.! Design! and! implementation! of! bioinformatic! pipelines! to! derive! genomic! variants!
from!MTBC! raw! sequence! data,!making! use! of! the! stateOofOtheOart!mapping! and! de-
novo!assembly!bioinformatic!tools.!
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In! summary,! the! objectives! of! this! work! involve! developing! bioinformatic! tools! for!




The!content!of! this! thesis! corresponds! to! that!of! five! research!papers! (Table!1.2),! in!
addition!to!the!Introduction!(Chapter!1)!and!Discussion!and!Further!Work!(Chapter!6),!
which!are!produced! specifically! for! this! thesis.!Chapters!2,!4!and!5!are! composed!of!































































































Chapter!2! corresponds! to!Research!Paper!2,! titled! ‘PolyTB:!A!genomic!variation!map!
for! Mycobacterium- tuberculosis’.! Chapter! 2! describes! the! implementation! of! the!
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genome! variation! discovery! pipeline! (Research! Paper! 2).! It! is! applied! across!
independent! WGS! data! sets! O! sourced! from! epidemiological,! DR! and! evolutionary!
studies! O! as! a! first! step! for! phylogenetic,! population! genetic! and! other! downstream!
analyses.! PolyTB! is! also! presented,! a! repository! hosting! the! discovered! genomic!





all!other!authors!and! technical!advice! from!MDP,!TGC!and!NM.! I!drafted,!wrote!and!





Chapter!3! is! composed!of! two! research!papers,! research!papers!1!and!3! (Table!1.2),!
both! related! to! Mtb! typing! from! whole! genome! sequences.! Approaches! that! can!
predict! traditional! genotypes! from! WGS! data! are! investigated,! leading! to! the!
development! of! SpolPred,! a! software! tool! for! accurate! determination! of! Mtb!
spoligotype! patterns! from!WGS! data! (Research! Paper! 1).! TGC! and! I! conceived! and!
designed!this!study.!I!developed!and!tested!SpolPred!software!with!the!contribution!of!
MDP,!who!helped!me!optimise!the!performance!and!speed!of!the!tool.!KM!carried!out!













produced! all! tables! and! figures.! RM,! TGC! and! I! wrote! the! paper! with! contributions!
from!all!other!authors.!Research!Paper!3!was!published!in!Nature-Communications!on!
the!1st!of!September!2014.!
Chapter! 4! corresponds! to! Research! Paper! 4! titled! ‘Rapid! determination! of! antiO
tuberculosis!drug! resistance! from!wholeOgenome!sequences’.!To!assess! the!potential!
benefits!of!a!whole!genome!approach!to!detect!DR!TB,!an!updated!library!of!mutations!
predictive!of!DR!has!been!curated! from! the! literature.!TB-profiler,! an!online! tool! for!
analyzing! raw! sequence! data! and! predicting! resistance,! has! been! implemented.! The!
prediction! of! strain! type,! based! on! strainOspecific! mutations,! has! been! added! to!
enhance! the! usefulness! of! this! tool.! RM,!AP,! TGC! and! I! conceived! and! designed! the!





I! searched! the! literature! and! curated! the! database! of! DROassociated! mutations.! I!
conducted! the! bioinformatic! analyses! to! derive! high! quality! genomic! variants,!
performed! comparisons! of! experimentally! determined! phenotypes! with! predicted!
ones,! and! performed! the! statistical! analysis! under! the! guidance! of! NM! and! TGC.! I!
produced!all!tables!and!figures!in!the!manuscript.!AP!led!the!sequencing!efforts.!RM,!
TGC!and!I!drafted,!wrote!and!finalised!the!manuscript!with!contributions!from!all!other!
authors.! Research! Paper! 4! was! submitted! for! publication! to! Genome- Biology! on!
December!2014.!
Chapter!5!corresponds!to!Research!Paper!5,!in!which!phenotypeOgenotype!association!
analyses! are! performed! and! novel! loci! associated! with! resistance! identified.! I!
conducted! the! bioinformatic! analyses! required! to! obtain! a! high! quality! data! set! of!












name! is! given! based! on! the! geographical! source! of! the! samples.! Only! two! studies!
consisted!of!samples!from!multiple!sources:!the!Global!key!strains!(Comas!et-al.!2013)!
and!WHOOTDR! studies! (Vincent!et- al.! 2012).! For! studies!with! publiclyOavailable!WGS!


















ERP000192c! 329! 49b! 61! Yes!
(42/329)!
Midlands,!UK!(Walker!et-al.!2013)! ERP000276c! 390! 75b! 112! No!













SRP002589d! 36! 50b! 37.5! Yes!
Lisbon,!Portugal!(Perdigão!et-al.!
2013)!
ERP002611e! 84! 100a! 104! Yes!
Karonga,!Malawi!(A)!(GuerraO
Assunção!et-al.!2014)*!
ERP000436c! 353! 75a! 183! Yes!
Karonga,!Malawi!(B)!(GuerraO
Assunção!et-al.!2014)!
ERP000436c! 1662! 75a! 102! Yes!
China!(H.!Zhang!et-al.!2013)! SRA065095f! 161! 75a! 113! Yes!
Djibouti!(Blouin!et-al.!2012)! ERP001885g! 7! 75a! 75! No!
Ethiopia!(Firdessa!et-al.!2013)! ERP001567h! 4! 75a! 95! No!
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Porto,!Portugal! O!e! 128! 100b! 157! Yes!
Karachi,!Pakistan! O!e! 42! 100b! 448! Yes!
Brazil! O!e! 108! 100b! 110! Yes!
Bulgaria! O!e! 17! 100b! 155! No!
Colombia! O!e! 15! 100b! 111! Yes!
India! O!e! 17! 100b! 59! No!
Japan! O!e! 4! 100b! 283! No!
Netherlands! O!e! 14! 100b! 389! Yes!
Peru! O!e! 104! 100b! 290! Yes!
South!Africa! O!e! 174! 100b! 188! Yes!
Vietnam! O!e! 50! 100b! 192! Yes!
WHOOTDR! O!e! 190! 100b! 123! No!
aSequenced!using! Illumina!HiSeq2000,! ! bSequenced!using! Illumina!Genome!Analyzer! II,! ! CSequenced!at!
the!Wellcome!Trust!Sanger! Institute,! ! dSequenced!at!Simon!Fraser!University,! ! eSequenced!at! the!King!
Abdullah!University!of!Science!and!Technology! (KAUST),! ! fSequenced!at! the!Beijing!Genomics! Institute!
(BGI),! ! gSequenced!at! the! Institut!de!Génétique!et!Microbiologie,!Université!Paris!Sud,! ! hSequenced!at!
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few!years! B! sourced! from!epidemiological,!DR!and!evolutionary! studies! in!Mtb! B! and!
deposited!as! raw!sequence! files.!The!aim!of! the!work!presented! in! this!chapter! is! to!
process! this!wealth!of!data,!mine! the!genetic!variation! in! it!and!present! it! to! the!TB!
community!in!an!integrated!and!intuitive!manner.!
2.1 INTRODUCTION"
SNPs,! indels! and! other! genetic! polymorphisms! derived! from! WGS! provide! enough!
discriminatory!power!to!assess!natural!variation!in!populations.!These!include!variants!
associated! with! the! hostBpathogen! relationship,! including! virulence! factors,! drug!
susceptibility! determinants! and! immune! modulator! factors! with! importance! on! the!
clinical! manifestations! (Ford! et% al.! 2012).! Due! to! the! low! mutation! rate! (Bryant,!
Schürch,!et%al.!2013)!and!limited!genomic!diversity!of!MTBC,!the!application!of!WGS!in!
clinical!settings!is!particularly!effective!for!Mtb%(Köser!et%al.!2012).!
After! the! first!Mtb! genome! was! sequenced! in! 1998! (Cole! et% al.! 1998),! another! 26!
complete! ‘reference’! genomes! have! been! sequenced! and! made! publicly! available!
(NCBI!2014).!Databases!like!the!Mycobacterial!Genome!Divergence!Database!(MGDD)!
(Vishnoi!et%al.!2008),!the!Single!Nucleotide!Polymorphism!Database!(dbSNP)!(Smigielski!
et% al.! 2000),! and! Tuberculosis! Database! (TBDB)! (Reddy! et% al.! 2009)! curate! genomic!




Tuberculist! provides! exhaustive! and! updated! functional! information! such! as! operon!
annotation!or!protein!information!(Lew!et%al.!2011).!
The!TB!community!has!a!number!of!available!webBbased!databases!and!tools!to!exploit!
the! existing!molecular! epidemiological! data! (Shabbeer!et% al.! 2012),! SNP! repositories!
(Stucki! &! Gagneux! 2012)! and! manuallyBannotated! genomes! (Sandgren! et% al.! 2009).!
Nevertheless,! there! is! no! tool! harbouring! genetic! polymorphisms! derived! from!WGS!
projects! integrated! with! geographic! distribution,! strain! type! information! and!
population! structure! visualisation.! Despite! the! number! of! WGS! data! sets! stored! in!
public! repositories! like! the! ENA! or! SRA! (Short! Read! Archive),! users! cannot! browse,!
compare! and! contextualise! the! genomic! variants! resulting! from! these! studies.!
Clinicians,! epidemiologists! and! researchers! working! on! TB! would! benefit! from! a!
resource! allowing! the! investigation! of! genetic! variation! at! genes! of! interest! and!
geographic!distribution!of!strains!and!clinically! important!genetic!variants!such!as!DR!
markers.!
To! fill! this! gap,! PolyTB%was! developed,! a! webBbased! tool! to! display! MTBC! genetic!
polymorphisms! derived! from! publicly! available!WGS! datasets.! A! catalogue! of! SNPs,!
small! indels! and! large! deletions! was! compiled! by! employing! the! stateBofBtheBart!
variation!discovery!software!(Alkan!et%al.!2011).!Variants!can!be!investigated!through!a!
genome!browser!reporting!their!chromosome!coordinates,!and!a!world!map!showing!
their! global! allele! distribution.! Additionally,! the! construction! of! phylogenetic! trees!











the! ENA! (http://www.ebi.ac.uk/ena/).! All! isolates! (n! =! 1,627)! had! been! sequenced!
using! Illumina! pairedBend! technology! (IlluminaBGAII! or! HiSeq! 2000).! For! each! of! the!
samples,!Trimmomatic!software!version!0.27!(Lohse!et%al.,!2012)!was!used!to!clean!the!
raw!data,! removing! low!quality! reads! and! lowBquality! 3’! ends! of! reads,! and! keeping!
only!reads!at!least!36!base!pairs!long,!with!nucleotides!above!Q20.!Filtered!sequences!
were! then! aligned! to! the! H37Rv! reference! genome! (Genbank! accession! number:!
NC_000962.3)!using!the!BWA%mem%algorithm!(version!0.7.9aBr786)! ! (Langmead!et%al.!
2009).! Default! options! were! used! but! the! ‘minimum! score! to! output’! which! was!
increased!to!50!(BT!option),!resulting!in!one!alignment!file!of!BAM!format!per!sample!
(Figure!2.1).!SAMtools/BCFtools%(SAMTOOLS)!(Li!et%al.!2009)!version!0.1.18!was!used!to!
call!SNPs!and!small! indels!using!default!options!but! the!minimum!read!depth! (set! to!
10)!and!the!maximum!read!depth!(set!to!2000).!GATK! (McKenna!et%al.!2010)!version!




Schatz! 2012)! was! used! to! calculate! mappability! values! along! the! whole! reference!
genome! using! a! kBmer! length! of! 50bp! and! 0.04%! of! allowed! substitutions! while!










sorted! proportion! of! missing! calls! was! plotted! for! all! isolates! and! a! clear! inflection!
point! found! at! around! 15%,! which! was! then! used! as! a! quality! threshold! to! filter!
samples!(Supplementary!Figure!1).!
Large! deletions! (>100bp)! were! determined! using! a! combination! of! tools! based! on!
pairedBend,! splitBread! and! DOC! approaches.! In! particular,% Breakdancer! (Chen! et% al.!
2009),!CREST%(Wang!et%al.!2011),!Pindel%(Ye!et%al.!2009),!Delly!(Rausch!et%al.!2012)!and!





with! high! similarity! (>95%),! the! contig! was! considered! a! crossBjunction! contig! (CJC)!
(Wang! et% al.! 2011).! Deletions!without! at! least! one! CJC!were! considered! to! be! false!
positives! and!were! therefore!discarded.!Deletions! in! PE/PPE! genes!were! filtered!out!
due!to! the!complexity!of! such!regions.!These!genes!are!an! important!source!of! false!
positives!(Roetzer!et%al.!2013).!
All!validated!deletions!were!merged!when!having!a!mutual!overlap!greater!than!95%.!
Also,! only! validated! deletion! sites! predicted! by! at! least! two! tools! or! occurring! in! at!




A! set! of! 16! publicly! available! complete! Mtb! genomes! were! downloaded!
(Supplementary! Table! 1).! All! genomes! were! aligned! against! the! H37Rv! reference!
genome! (NC_000962.3)! using!BWA%MEM! (Li! &! Durbin! 2010).! Once! again,! SNPs! and!
small! indels!were! identified! using! SAMTOOLS! and!GATK,! and! the! overlapping! set! of!
variants! retained.! Large! deletions! in! complete! genomes! were! derived! with! an!
implemented! pipeline! consisting! of! nucmer,! showJdiff% (Kurtz! et% al.! 2004)! and! AGE!
software!(Abyzov!&!Gerstein!2011).!!!
2.2.3 Population"structure"
Strain! spoligotypes! for! all! isolates! were! derived! from! FASTQ! files! using! SpolPred!
(Section!3.2.2).!The!bestBscoring!maximum!likelihood!phylogenetic!tree!was!computed!





web! pages! because! they! all! are! free,! openBsource! and! easily! combined.! PHP! is! the!
scripting! language!working!on! the! server! side,!normally! enclosed! inside!HTML!pages!
and! passed! to! the! PHP! parser! on! the! server,! which! automatically! processes! it.! PHP!
output! is! always! HTML! eventually! sent! to! and! displayed! by! the! web! browser.!
JavaScript,!on!the!other!hand,!is!used!as!the!clientBside!(i.e.!Web!browser)!language.!It!
! 47! !
provides! the!means! by! which! elements! in! an! HTML! document! (such! as! text! boxes,!
bottoms,!lists,!etc)!can!be!accessed,!monitored!and!changed!onBtheBfly.!JavaScript!can!
gather! information! from! the! client! and! pass! it! to! a! PHP! script! on! the! server! to!
interactively!generate!dynamic!pages.!
Raw! data! has! been! initially! preBprocessed! to! be! stored! in! the! form! of! PHP! and! CSV!
files.! Raw! files! contain! information! about! the! samples! and! populations,! genomic!





and! their! variables! content! used! by,! another! group! of! PHP! pages,! the! ones! actually!




The!genome!browser! is! the!main! view!of! the!project;!where!genetic!polymorphisms!
are!displayed!for!the!chromosome!region!and!samples!selected!by!the!user.!!Figure!2.2!
shows! the! webBpage! structure.! JavaScript! plays! a! key! role! in! controlling! HTML!
elements! content! and! layout.! The! JavaScript! code! implemented! in! browser.js! file!
contains! specific! functions! to! load! CSV! documents! content! into! browser.php! HTML!
elements.! For! instance,! sample! names! and! locations! are! added! as! dropBdown! list!
! 48! !
options! in! this! page.! JavaScript! also! monitors! changes! made! by! the! user! on! HTML!








Flowchart! representing! the! Genome! Browser! View! architecture.! Documents! with! background! colour!
(PHP!and!CSV)!contain!processed!data:! related! to!sample!metadata! (green!background),! chromosome!
annotation!(orange!background)!and!genetic!polymorphisms!(sample.php!files!in!gray!background).!This!
data!is!accessed!by!PHP!files!implementing!most!of!the!functionality!(white!background)!including!image!







page.! For! instance,! browserimage.php! creates! an! image! with! colourBcoded! genetic!
variants.!





Flowchart! representing! the!Map!View!architecture.!Documents!with!background! colour! (CSV)! contain!
processed!data:!related!to!sample!metadata!(green!background)!and!chromosome!annotation!(orange!
background).!Allele!frequencies!across!each!population!are!stored!in!small!CSV!files!(snpX.csv,!indelX.csv,!
delX.csv! files! in! gray! background).! This! data! is! accessed! by! JavaScript! function! in! map.js! which!
implements!most!of!the!functionality!and!controls!the!HTML!elements!in!map.php.!
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Figure!2.3! shows! the!webBpage! structure.! In! this! case,! JavaScript! functions! in!map.js!
implement! most! of! the! functionality.! Allele! frequencies! for! SNPs,! indels! and! large!
deletions! across! geographical! populations! are! stored! in! CSV! files! in! mapSNPs,!
mapINDELs! and! mapDELs! folders! respectively.! For! a! given! selected! variant,! allele!
frequencies! at! all! populations! are! read! from! its! corresponding! file! and!drawn!as! pie!
charts!on!the!map.!Additionally,!spoligotype!frequencies!within!each!allele!portion!can!
also!be!displayed!in!the!form!of!concentric!pie!charts.!
The! construction! of! phylogenetic! trees! based! on!whole! genome! polymorphisms! has!
been! implemented!as!an!additional! tool! to! investigate! the!population! structure.!The!
aim! is! to!build!phylogenies! for! the!samples!selected!by!the!user!on!the! fly!and!draw!
the! resulting! trees! in! a! reasonable! amount! of! time,! namely! in! seconds.! ! Due! to! the!
large! number! of! samples! and! polymorphisms! to! consider,! distanceBmatrix! methods!
have!been!chosen!for!that!purpose!because!of!their!efficiency.!Other!methods!based!
on! parsimony! or!maximum! likelihood!would! be!more! timeBconsuming!when! dealing!
with!wholeBgenome!data.!However,!prior!to!running!the!distance!method!the!distance!
matrix! needs! to! be! calculated! from! multiple! alignments,! the! most! computationally!
expensive!step.!
As! shown! in! Figure! 2.4,! the! Phylogenetic! View! keeps! the! same! structure! as! the!
Browser! View! (Figure! 2.2).! JavaScript! functions! in% phy.js! collect! the! samples! and!
parameters! specified!by! the!user! required! for! building!both! the!distance!matrix! and!
phylogenetic!tree!and!passed!them!to!createtree.php.!The!phylogenetic!analysis!page!










and!GATK% consensus! variant! calls! using! genomic!mappability! criteria.! Isolates! having!




All!major!modern!MTBC! lineages! are! represented,! including! lineage! 1! (East! AfricanB
Indian! (EAI)! spoligotype! family,! 95! isolates,! 6.46%),! lineage! 2! (Beijing,! 246! isolates,!
16.73%),! lineage! 3! (Central! Asian! (CAS),! 170! isolates,! 11.56%)! and! lineage! 4! (715!
isolates,!of!which!119!X,!273!T,!266!LAM,!7!S!and!50!H).!Ancestral!lineages!represented!
include! seventeen!M.% africanum! cases,! 7! from! lineage! 5! (West! African! 1! family),! 10!
from!lineage!6!(West!African!2!family)!and!6!cases!of!M.%bovis.!Nearly!15%!of!isolates!















Figure! 2.5! shows! a! radial! phylogram! for! all! samples,! rooted! on!M.% bovis.%All! major!
MTBC!lineages!are!separated,!with!M.%bovis,!lineage!1,!2,!3,!5!and!6!isolates!clustered!
within! discrete! clades,! thereby! demonstrating! the! usefulness! of! SNPs! for! strain!


















clade! (X! spoligotype)! suggesting! they! all! resulted! from! the! clonal! expansion! of! the!
same!ancestor!(Gardy!et%al.!2011).!Similarly,!a!wellBdelineated!group!of!Beijing!isolates!
















to! a!median! SNP! density! of! 1! SNP! per! 4.9! kb.! SNP! density! in! coding! genes! (median!
0.20,! range!0!–!0.50!SNPs/kb)!was! found! to!be! lower! than! that! in! intergenic! regions!
(median!0.27,!range!0!–!0.81!SNPs/kb).!
Figure! 2.8! shows! the! SNP! density! calculated! across! all! gene! functional! categories! as!
annotated! in! Tuberculist! (http://tuberculist.epfl.ch/).! As! expected,! the! highly!





majority! found! in!single! isolates! (47.5%)!(Figure!2.9).!An!average!number!of!85!small!
indels!were!detected!per!sample!(range!0!–!199!indels).!Both!insertions!and!deletions!






















1).!A! total!number!of!12,887!SNPs,!6,749!small! indel!and!95! large!deletion! loci!were!
identified!from!whole!genome!comparisons!of!16!complete!Mtb!genomes!against!the!
H37Rv! reference.! The! WGSBderived! polymorphisms! were! compared! against! this!
validated! dataset! finding! an! overlap! of! 4,814! SNP,! 319! indel! and! 26! deletion! loci,!
namely!WGSBderived!variant!loci!present!in!at!least!one!of!the!Mtb!complete!genomes!
too.!These!overlapping!polymorphisms!were!found!to!be!more!frequent!(17.2%,!18.4%!
and! 43.4%! of! samples! for! SNPs,! indels! and! deletions)! than! those! not! shared! with!
complete!genomes!(0.3%,!0.6%!and!1.0%).!Overall,!these!results!indicate!set!of!WGSB




designed! to! facilitate! the! exploration!of!MTBC!genetic! variation! (74,039! SNPs,! 4,820!
indels! and! 800! deletion! sites)! at! a! genome! and! global! scale.! The! tool! consists! of!
complementary! and! integrated! genome! browser,! map! and! phylogenetic! views.! The!
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genome% browser! shows! SNPs,! small! indels! and! large! deletions,! colourBcoded! and!




Genetic! variants! are! shown! at! the! rpoB% and! rpoC% genes,! loci! known! to! be! associated! with! RMP!
resistance.!Synonymous!SNPs!(sSNPs)!are!coloured!in!black,!nonBsynonymous!SNPs!(nsSNPs)!in!red!and!
small! insertions!and!deletions!in!blue!and!green,!respectively.!Cursor!movement!over!variants!displays!
an! information! box! with! further! annotation! including! nucleotide,! codon! and! amino! acid! changes! for!
SNPs,!and! length!and!sequence! for! indels.!Location!and!Spoligotype%tracks!are!placed!as!colourBcoded!
vertical!bars!at!the!left!hand!side!of!the!genomic!plot!and!provide!information!for!samples.!Sixty!isolates!
are! shown,! 30! from!Malawi! (colourBcoded! in! red! in! the! Location! bar)! and!30! from!Uganda! (shown! in!
green).! Patterns! of! SNP! differences! can! be! observed! when! comparing! isolates! from! different!
populations:! Kampala! isolates! harbour!many!more! nsSNPs! at! rpoB% gene! than!Malawian! isolates.! The!
observed! nsSNPs! are! likely! to! be! the! underlying! cause! of! RMP! resistance! (Clark!et% al.,! 2013).! In! fact,!
rpoBJ516! (A!T!SNP!at!761,110!bp),! rpoBB526! (G!T!761,139!bp!and!A!G!761,140!bp)!and! rpoBJ531!
(C!G! 761,155! bp)! mutations! are! observed! in! Ugandan! isolates,! and! correspond! to! nsSNPs! already!
reported!as!RMP!resistance!markers!(Sandgren!et%al.!2009).!
Browsing!options!allow!the!user!to!navigate!to!the!genes!or!regions!of! interest,!with!
annotation! tracks! (top)! and! sample! descriptions! (left! side)! providing! context! for! the!
variation.! Search% functionality! has! been! implemented! to! enable! the! investigation! of!
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polymorphisms! at! genes! of! interest! given! their! locus! tag,! functional! annotation,!
description! key! words! or! association!with! antiBTB! DR! (Sandgren! et% al.! 2009).! Figure!
2.11!shows!differences!on!polymorphism!patterns!between!isolates!from!two!different!
populations! in! the!neighbouring! rpoB%and! rpoC! genes,!a! region!associated!with!RMP!
resistance.!Known!RMP! resistance!markers! including! rpoBB516! (corresponding! to! the!
observed!761,110!bp!A!T! SNP),! rpoBB526! (761,139!bp!G!T! and!761,140!bp!A!G)!
and!rpoBB531!(761,155!bp!C!G!mutation)!are!observed!in!Ugandan!isolates.!They!all!




the! evolution! of! infection! and! treatment! outcome! such! as! those! associated! with!
virulence,!nitric!oxide!production!and!apoptosis!among!other!possibilities. 
Overall,!the!browser!view!aims!to!provide!a!visualisation!tool!for!the!identification!of!
differential! variation!patterns! among! isolates! and!populations! at! the! same! region!or!
between!different!regions!under!study.!
The!map% view! shows! the! global! allele! distribution! for! a! polymorphism! of! interest.!
Allelic! frequencies! for! the! chosen! polymorphism! are! displayed! as! pie! charts! at! the!
geographical! regions! from!where! sequenced!samples!were!collected,!either!alone!or!





lineage! 1! (EAI! spoligotype! family)! across! studies! (only! Tanzanian! and! KarongaB
Malawian!populations!shown).!The!main!purpose!of!the!map%view!is!to!provide!a!tool!
to!assess!the!spread!and!frequency!of!WGSBderived!genomic!variants!at!a!global!scale!
as! well! as! to! enable! the! identification! of! populationB! and! strain! specific!
polymorphisms.!
 
Figure" 2.12"SNP! associated!with! lineage! 1! (EAI)! in! Tanzanian! and! KarongaBMalawian!
populations!(Map!view)"
Allele! frequencies! are! shown! for! the! chosen! polymorphic! position! as! pie! charts,! either! alone! or!
combined! with! in% silico% inferred! spoligotypes! (Coll! et% al.,! 2012)! to! allow! the! visual! detection! of!
relationships!between!certain!alleles!and!strain!types.!Reference!allele!frequency!portions!on!pie!charts!
are! coloured! in! blue!while! alternative! allele! (i.e.! nonBreference)! frequencies! are! shown! in! red.! Outer!
chart! portions! representing! relative! strain! type! frequencies! are! colourBcoded! by! main! spoligotype!
families! (AFRI,! BOV,! Beijing,! CAS,! EAI,! LAM,! Manu,! S,! T! and! X).! In! this! particular! case,! the! SNP! at!





















the! tree! to!highlight! the! correlation!between! lineage!and! location!with!phylogenetic!
clustering.! The! aim! of! the! phylogenetic! view! is! to! assess! the! genetic! relatedness! of!
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genotyping! data! for! MTBC! (Lew! et% al.! 2012),! there! is! no! such! tool! gathering! the!
increasing! amount! of! genetic! polymorphisms! derived! from! WGS! projects! (Stucki! &!
Gagneux! 2012).! Given! the! magnitude! of! the! genomic! data! being! generated! on! a!
routine!basis,!efforts!must!be!focused!on!analysing!and!presenting!this!data!in!a!robust!
and!useful!manner!for!the!research!and!public!health!communities.!In!this!sense,!the!
present! release! of! PolyTB% makes! it! the! largest! openBaccess! repository! of! genetic!
polymorphisms! derived! from!WGS! projects.! The! expandable! database! goes! beyond!
SNPs,!and!includes!small!indels!and!large!deletions!derived!by!employing!the!stateBofB
theBart! variation! discovery! software.% Robust! quality! control! and! standardised!
procedures!applied!across!samples!ensures!that!the!datasets!are!directly!comparable.!
Overall! small! indel!and! large!deletion!densities! in!coding!genes!were!5!and!17! times!
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smaller! than! in! nonBcoding! regions! respectively.! This! considerable! reduction! in!
polymorphism! density! at! coding! regions! can! be! explained! in! terms! of! the! potential!
deleterious!effects!of!these!variants!in!the!genome,!leading!to!their!selective!removal!
by!purifying!selection.!
Although! MTBC! strains! were! historically! confined! to! their! endemic! geographical!
locations,!migration!has!led!to!a!more!global!distribution.!Modern!modes!of!transport!
mean! that! TB! is! now! easily! spread! across! regions! and! continents.! It! is! possible! to!
monitor! the! spread! of! lineages! through! phylogenetic! markers! as! well! as! track! DR!
markers,!which! emerge!de% novo! and! independently! of! strains,!with! a! discriminatory!
power! never! achieved! before.! In! this! context,! the!map! view! provides! a! tool! for! the!
epidemiological! surveillance!of!TB! through! the!geographic!distribution!of! strains!and!
clinically! important! genetic! variants,! such! as! those!driving!DR.! Indeed,! knowledge!of!
transmission!across! lineages!and!continents! is!essential! to! those!who!need!to!devise!
national! prevention! and! control! programmes.! Similarly,! the! main! purpose! of! the!
phylogenetic! view! is! to! assess! the! genetic! relatedness! of! isolates! within! and! across!
studies! as! well! as! comparing! genetic! clustering! with! traditional! spoligotypes! and!
lineages.!!
Recently,! other! tools! similar! to!PolyTB! have!been!published.! The! tbvar! tool! contains!
469!isolates!and!29,000!SNPs!(Joshi!et%al.!2014).!Genomic!variants!(limited!to!SNPs)!are!
displayed! through! a! table! and! genome! browser! views.! SNPs! are! annotated,! their!
functional! impact! predicted! using! the! SIFT! score! (Ng! &! Henikoff! 2003)! and! DR!

















Number!of!samples! 469! 1,084! 1,470"






















a! total! of! 1,084! MTBC! samples! and! 69,000! variants! (SNPs! and! indels)! from! Russia.!
Unlike! tbvar,! this! resource! contains!a!broad! spectrum!of!metadata!attached! to!each!
sample,! including! TB! clinical! outcome,! year! and! place! of! isolation! and! DR! profiles.!
Genetic!polymorphisms!can!be!investigated!through!a!browser!and!map!views,!like!in!
PolyTB.! The!main! limitation! of!GMTV% is! that! available! data! is! restricted! to! only! one!
study! and! therefore! only! certain! lineages! are! represented.! Overall! PolyTB! harbours!
more! samples! (1,470)! with! representatives! of! all! major! lineages! and!more! types! of!
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genetic! variants! (SNPs,! indels! and! large! deletions).! Furthermore,! PolyTB% includes! a!
phylogenetic! view,! which! enables! the! study! of! phylogenetic! relationships! among!
samples! of! the! same! study! and,! more! importantly,! of! samples! across! independent!




Current! efforts! on! discovery,! visualisation! and! accessibility! of! genetic! variants! from!
WGS!studies!must!be!accompanied!with!efforts!on!annotation!of!these!variants!(Stucki!
&!Gagneux!2012).!This! involves! identifying!strainBspecific!mutations,!which!can!serve!
as! phylogenetic!markers! for! strain! classification,! DRBconferring!mutations,!which! are!
crucial! for! the!development!of!new!and!faster!diagnostic!methods!to!detect!DR,!and!
mutations! affecting! the! bacterial! phenotype! in! various! ways,! which! may! have! an!
impact! on! the! outcome!of! TB! infection! and! disease.! In! the! following! chapters! these!
points!will!be!addressed.!StrainBspecific!and!DRBassociated!mutations!in!MTBC!will!be!
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SNP! classification! system! that! can!discriminate!all! known!circulating! strain! types!has!
not! been! developed.! Classical! genotyping! methods! are! still! broadly! employed! and!
results! from! these! are! not! easily! comparable! with! WGS! data.! In! this! regard,! this!




Infection!with!bacteria!of! the!MTBC! results! in!a!variety!of!outcomes! including! latent!
infection! and/or! progression! to! pulmonary! or! extraGpulmonary! manifestations! of!
disease.! Such! diversity! has! been! historically! attributed! to! host! and! environmental!
factors,!and!the!MTBC!was!previously!considered!genetically!monomorphic! in!nature!
(Lin! &! Flynn! 2010).! However,! the! development! of! typing!methods! that! discriminate!
strains! into! distinct! lineages! and! subGlineages! has! demonstrated! previously!
unrecognized!diversity.! It!has!been!shown!that!strain!type!may!play!a!role! in!disease!
outcome,!variation!in!vaccine!efficacy!(López!et#al.!2003)!and!emergence!of!DR!(Ford!et#
al.! 2013).! Different! strains! of! MTBC! have! produced! distinct! biological! responses! in!
experimental!models!and!can!affect!clinical!presentation!(Nahid!et#al.!2010;!Thwaites!
et#al.!2008;!Caws!et#al.!2008).!Strain!type!may!also!influence!disease!epidemiology!as!
in! some! settings! it! is! associated! with! the! presence! or! absence! of! clustering! due! to!
recent! transmission! (KatoGMaeda! &! Kim! 2010).! LineageGspecific! differences! in! the!
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virulence! of! clinical! isolates! have! been! reported! across! independent! experimental!
systems! with! modern! lineages,! such! as! Beijing! and! EuroGAmerican! Haarlem! strains!
believed! to! exhibit!more! virulent! phenotypes! compared! to! ancient! lineages,! such! as!
East! African! Indian! and! M.# africanum! strains! (Reiling! et# al.! 2013).! The! molecular!
mechanisms! and! genetic! factors! responsible! for! the! described! differences! in!




isolates! between! laboratories! and! regions! worldwide.! Over! the! last! two! decades,!




lineages! have! been! defined! (1! IndoGOceanic,! 2,! EastGAsian! including! Beijing,! 3! EastG
AfricanGIndian,!4!EuroGAmerican,!5!West!Africa!or!M.#africanum!I,!6!West!Africa!or!M.#
africanum! II),! distinct! from! a! M.# bovis# clade.! Lineages! 1,! 5! and! 6! are! considered!
“ancient”,!and!2!to!4!“modern”.!A!novel!phylogenetic!lineage!of!MTBC!which!appears!




Genotyping! has! been! used! extensively! with! epidemiological! data! to! further!
understanding!of!TB!(Demay!et#al.!2012).!For!example,!at!the!individual!level,!cases!of!
recurrence! or! treatment! failure! can! be! explained! in! terms! of! reactivation! with! the!
same!strain,!exogenous!reGinfection!or!due!to!polyclonal!infection!(Ford!et#al.!2012).!At!
a! population! level,! the! origins! and! transmission! dynamics! of! outbreaks! can! be!
determined!(Walker!et#al.!2013;!Gardy!et#al.!2011;!Bryant,!Schürch,!et#al.!2013),!!whilst!
at!a!global! level,!TB!genotypic! lineages!have!been!defined!and!used!to!monitor! their!
geographical!distribution!(Demay!et#al.!2012).!
While! providing! valuable! information,! standard! genotyping! methods! have! several!
limitations.! First,! the! repetitive! nature! of! genetic! polymorphism! used! by! molecular!
techniques! makes! them! highly! prone! to! convergent! evolution! (Comas! et# al.! 2009),!
reducing! their!usefulness! as!phylogenetic!markers.! Second,! the!discriminative!power!
differs! between! methods,! meaning! that! results! from! different! techniques! are! not!
always! comparable! (Comas! et# al.! 2009).! Furthermore,! isolates! with! identical! DNA!
fingerprints!have!been!reported!to!harbour!significant!genomic!diversity!(Niemann!et#
al.!2009).!Therefore!standard!genotyping!tools,!which!are!based!on!less!than!1%!of!the!
genome,! may! not! be! able! to! accurately! resolve! transmission! chains! and! distinguish!
disease! relapse! from!exogenous! reGinfection!conclusively.!On! the!contrary,! SNPs!and!
large! sequence! polymorphisms! (LSP)! are! ideal! markers! for! defining! phylogenetic!
relationships.! The! low! mutation! rate! (Schürch! et# al.! 2010)! and! resulting! limited!





2006)! markers! to! construct! reproducible! and! unambiguous! phylogenies! in! MTBC.!
Given!the!predominantly!clonal!population!structure!of!MTBC,!they!all!produce!largely!
congruent!phylogenies!(Gagneux!&!Small!2007).!Spoligotype!strain!classification!is!also!
comparable! to! that! assigned! by! LSP! and! SNP! markers.! Indeed,! spoligotype! families!
often!appear!to!be!subGlineages!within!the!main!six!lineages!(KatoGMaeda!&!Gagneux!




phylogenetic! markers,! a! new! SNPGbased! classification! system! is! required! that! can!
overcome! the! limitations!of! current! genotyping!methods.!At! the! same! time,! in# silico#














The! popular! spoligotyping! approach! is! a! genotyping! technique! that! exploits! the!
polymorphism!harboured!at!the!direct!repeat!locus!of!Mtb#(Kamerbeek!et#al.!1997).!It!
is! based! on! the! PCR! amplification! of! 43! short! unique! sequences! (termed! spacers)!
found!between!wellGconserved!36Gbp!direct!repeats!and!the!subsequent!hybridisation!
of! the! products! onto! a! membrane! with! oligonucleotides! complementary! to! each!
spacer.! Since! strains! vary! in! the! occurrence! of! particular! spacers,! each! sample!
produces!a!distinctive!spot!pattern!then!translated!into!a!numerical!code!of!15!digits,!
known!as!octal!code!(Figure!3.1).!
The! strategy! implemented! to! derive! the! spoligotype! patterns! (i.e.! octal! codes)! from!
sequence! data! consisted! of! screening! raw! reads! and! avoided! timeGconsuming! postG














Experimental! steps! in! spoligotype! determination.! (1)! Structure! of! the! direct! repeat! locus! in# Mtb!
genome.!(2)!PCR!amplification!using!primers!complementary!to!the!conserved!direct!repeat!region.!(3)!
Hybridisation!of!an!amplified!DNA!fragment!onto!the!membrane!containing!spacer!sequences!as!probes.!




using! Illumina–GAII! 76Gbp! pairedGend! technology! at! the! Sanger! Institute! (Study!
accession:! ERP000520),! and! for! most! of! which! (44/51! isolates)! experimentally!
determined! spoligotype! was! available.! SpolPred# output! was! compared! against! the!
experimental! results! in! order! to! determine! its! prediction! accuracy.! Furthermore,!
SpolPred!performance!was!tested!on!a!64!bit!Ubuntu!Linux!computer!with!a!3.07GHz!
processor! and! 8Gb! of! RAM.! As! expected,! running! time! per! FASTQ# file! increased!
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readGspacer! matches! and! corresponding! octal! code.! Spoligotypes! are! derived! using! the! latest!
international!spoligotype!database!(SITVITWEB)(Demay!et#al.!2012).!
3.2.3 In#silico"determination"of"lineages"by"regions"of"difference"
LineageGspecific! LSPs!or!RDs! types!were! identified! from! (Gagneux!et#al.! 2006)! (Table!
3.1).! This! system!makes! use! of! 19! phylogenetically! informative! and! lineageGspecific!
deletions!to!define!the!global!population!structure!of!MTBC,!which!is!often!regarded!as!
the! goldGstandard! classification! system! for!MTBC! lineages.! All! samples! in! the! global!
collection!were!also!genotyped!based!on!this!system.!Reads!covering!RDs!(+/G!300bp)!
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were! extracted! from! alignment! (BAM# format)! files! and! subsequently! de# novo!
assembled!using!Velvet!(Zerbino!&!Birney!2008).!If!an!assembled!contig!was!split!into!








105! 79567! 83034! 3467! Rv0071GRv0074! EastGAsian! 2!
115! 453364! 455971! 2607! Rv0376cGRv0378!
AmericasGEurope/EuroG
American! 4!
122! 669793! 670964! 1171! Rv0576!
AmericasGEurope/EuroG
American! 4!
142! 1332182! 1335033! 2851! Rv1189GRv1192! EastGAsian! 2!
150! 1896862! 1899349! 2487! Rv1671GRv1674c! EastGAsian! 2!
174! 2237049! 2240699! 3650! Rv1992cGRv1997!
WestGAfrica/EuroG
American! 4!
181! 2535429! 2536140! 711! Rv2262cGRv2263! EastGAsian! 2!
182! 2545194! 2551674! 6480! Rv2270GRv2280!
AmericasGEurope/EuroG
American! 4!
183! 2585853! 2588770! 2917! Rv2313cGRv2315c!
AmericasGEurope/EuroG
American! 4!
193! 2704306! 2704807! 501! Rv2406cGRv2407!
AmericasGEurope/EuroG
American! 4!
207! 3120521! 3127920! 7399! Rv2814cGRv2820c! EastGAsian! 2!
219! 3448504! 3451396! 2892! Rv3083GRv3085!
AmericasGEurope/EuroG
American! 4!
239! 4092077! 4092919! 842! Rv3651! IndoGOceanic! 1!
702! 216795! 218516! 1722! Rv0186! WestGAfricanG2! 6!
711! 1501713! 1503655! 1943! Rv1333GRv1336! WestGAfricanG1! 5!
724! 2265112! 2266239! 1128! Rv2018GRv2019!
CentralGAfrica/EuroG
American! 4!
726! 3904958! 3906706! 1749! Rv3485cGRv3487c!
WestGAfrica/EuroG
American! 4!
750! 1710767! 1711556! 790! Rv1519GRv1520! EastGAfricanGIndian! 2!





The! bestGscoring!maximum! likelihood! phylogenetic! tree!was! computed! using!RAxML!
v7.4.2! (Stamatakis! et# al.! 2008)! based! on! 91,648! sites! spanning! the! whole! genome.!
Given!the!considerable!size!of!the!dataset!(1,601!samples!x!91,648!SNP!sites),!the!rapid!
bootstrapping!algorithm!(N=100,!x=12345)!combined!with!maximum!likelihood!search!
was! chosen! to! construct! the!phylogenetic! tree.! The! resulting! tree!was! rooted!on!M.#
canettii! (Genbank! accession! number:! NC_019950.1)! and! nodes! were! annotated.!
Subsequently,! the! ancestral! sequence! at! all! internal! nodes! was! computed! using!
DnaPars!from!the!Phylip!package!(Felsenstein!1989).!The!main!lineage!and!subGlineage!
defining!nodes!were! initially! identified!by! integrating! the! topology!of! the! SNPGbased!
phylogenetic!tree!with!the!presence!of!particular!RDs!and!spoligotype!composition!of!
the!clade.!Bootstrap!values!were!computed!to!assess!the!confidence!of!each!clade!and!
ensure! that! all! lineageGdefined! nodes! were! highly! supported! (95G100%).! For!




For! each! lineage! and! subGlineage,! the! dataset! was! split! into! two! populations:! one!
containing! all! samples! descending! from! the! cladeGdefining! node! and! the! other! with!
remaining! samples.! The!FST!measure! (Weir!&!Hill,! 200)!was! then! calculated! for! each!
SNP! to! identify!markers!with! complete!betweenGpopulation!allele!differentiation! (FST!
>0.99).!Similarly,!the!ancestral!reconstructed!sequence!for!the!cladeGdefining!node!was!
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compared! to! its! closest! ancestral! node,! and! the! SNP! differences! derived.! A! highG
confidence! set! of! cladeGspecific! SNPs! was! obtained! by! selecting! those! at! the! cladeG
defining! internal!node!and!having!FST!values!of!>0.99!in!between!group!comparisons.!
To! ensure! that! cladeGspecific! SNPs!were! also! suitable!markers! for! their! use! in! strain!
typing!assays,! the! following! filtering!criteria!were!applied:! (1)!only!synonymous!SNPs!
were!retained!as!they!are!generally!under! lower!selection!pressure,! (2)!SNPs!at!nonG
coding!regions!were!discarded!since! indels!are!usually!more!frequent.!The!density!of!
small! indels! and! large! deletions! is! five! and! seventeen! times! smaller,! respectively,! in!
coding! regions! of! the! genome! compared! to! nonGcoding! (Coll! et# al.! 2014)! (Section!
2.3.1),!and!(3)!only!essential!genes!were!used!(Stucki!et#al.!2012).!
The! set! of! DR! associated! genes! was! compiled! from! TBDreamDB!





SpolPred! was! initially! applied! to! 51! Ugandan!Mtb# isolates! for! which!WGS! data! and!






Showing! from! left! to! right:! isolate! number,! experimentally! determined! and! SpolPred! inferred! SIT!
numbers!(in!square!brackets)!and!SpolPred!predicted!spoligotype.! Isolates!with!no!laboratory!data!are!
pointed! by! black! arrows! and! unknown! SIT! numbers! indicated! by! dash! symbols.! Isolates! with! no!
matching!experimental!and!in#silico!SIT!number!are!pointed!by!white!arrows.!
The! five! nonGmatched! in# silico#and! experiment! results!were! due! to! the! increased! in#
silico! sensitivity! of! the! detection! of! spacer! 15! in! the! five! samples! and,! additionally,!
spacer! 26! in! one! sample.! When! the! original! hybridization! blots! were! checked,! an!
irregular! signal!distribution! for! spacer!15!across!all! samples!was!noted.!Some!signals!
were!either!too!faint!or!just!not!detectable!to!be!manually!assigned!as!being!present.!
Although! predicted! spoligotypes! remained! unchanged! for! samples! 26! and! 48,! the!





clustered!with! isolates! of! the! same! predicted! spoligotype! (Figure! 3.3).! These! results!








M.# bovis! (n=11)! (Supplementary! Table! 3).! A! total! of! 91,648! SNPs! were! identified,!!
54.6%! were! observed! in! a! single! sample! (Supplementary! Figure! 2),! 89.2%! were! in!
coding! regions,! and! 63.5%! resulted! in! nonGsynonymous! changes! in! amino! acids.! The!
SNPGbased! phylogenetic! tree! demonstrated! a! clustering! largely! congruent! with!
published!MTBC!phylogenies!(Figure!3.4).!MTBC!main!lineages!(1G7!and!M.#bovis)!and!
subGlineages! were! subsequently! identified! based! on! the! spoligotype! and! RD!
composition! of! the! clades! in! the! SNPGbased! phylogeny! (see! Section! 3.2.4).! The!
phylogeny!revealed!the!presence!of!new!clades!for!which!RDs!do!not!discriminate.!In!









Although! estimates! of! genetic! diversity! may! be! influenced! by! sampling! bias,! the!
greatest! nucleotide! diversity! was! observed! in! lineages! 1! (nucleotide! diversity! π! =!
0.0103)! and! 6! (π! =! 0.0093),! and! the! least! within! lineage! 2! (π! =! 0.0039)! and! 3! (π! =!
0.0040)! strains! (Table! 3.2).! Although! spoligotypes! tended! to! cluster! within! specific!







All! previously! reported! lineageGspecific! LSPs! or! RDs! (Gagneux! et# al.! 2006)! were!
detected,!and!their!distribution!was!consistent!with!clades!in!the!SNPGbased!phylogeny!
(Figure! 3.4).! There! was! no! evidence! of! homoplasy! events! using! LSPs,! further!
demonstrating!their!robustness!as!phylogenetic!markers.!!
As! expected,! isolates! from! lineage!1!harboured! the!RD239!deletion!and!had!EAIGlike!
spoligotypes.! Two! natural! subGlineages! designated! 1.1! and! 1.2! contained! distinctive!
spoligotype! compositions! (Table! 3.3).! The! BeijingGspecific! RD105! deletion! was!
restricted!to!lineage!2,!whilst!others!(RD207,!RD181,!RD150!and!RD142)!were!observed!
downstream! from! the! common! ancestor! (Figure! 3.4),! defining! subGlineages! within!
Lineage" 1" 2" 3" 4" 5" 6" 7"
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and! included! subGlineages! for! CAS1GDelhi! (33.9%),! CAS1GKili! (53.4%),! CAS! (6.3%)! and!
CAS2! (5.3%)! spoligotypes.! All! nonGCAS1GDelhi! samples! were! grouped! into! the! same!
clade! (subGlineage! 3.1),! which! was! subGdivided! into! two! clades! harbouring! CAS1GKili!
and! CAS/CAS2! samples! respectively.! The! EuroGAmerican! lineage! has! been! the! most!
poorly!characterized!historically!(Filliol!et#al.!2006),!and!as!expected!using!spoligotypes!
there! was! evidence! of! nonGhomogeneous! subGlineages! (in! particular! T,! H! and! LAM!
families)!(see!Supplementary!Figure!3),!potentially!due!to!homoplasy!events!(Filliol!et#
al.! 2006).! The! phylogeny! revealed! 36! distinctive! clades! for! lineage! 4.! All! 10! EuroG
American! lineage! RDs! were! consistently! located! within! one! of! these! clades,! further!
subGdivision!was! achieved! and! clades!with! unreported! RD!were! identified! (e.g.! subG
lineages! 4.2,! 4.4,! 4.7! and! 4.9)! (Figure! 3.4).! Representatives! of! Haarlem! (subGlineage!
4.1.2.1),! Cameroon! (4.6.2),! LAM! (4.3),! SGtype! (4.4.1.1),! TUR! (4.2.2.1),!Uganda! (4.6.1),!
Ural! (4.2.1)! and!XGtype! (4.1.1)! strains!were! all! identified! (Table! 3.3).! Consistent!with!
previous!phylogenetic!studies,!strains!belonging!to!M.#africanum!were!split!into!WestG
African! lineages! 1! and! 2,!where! the! latter! is! phylogenetically! closer! to! the!M.# bovis#











1! Indo,!Oceanic! 121! EAI! 18! 239! 473!




1.1.1! Indo,!Oceanic! 10! EAI4,!EAI5! 4! 239! 57!
1.1.1.1! Indo,!Oceanic! 5! EAI4! 1! 239! 138!
1.1.2! Indo,!Oceanic! 30! EAI5,!EAI3! 9! 239! 154!
1.1.3! Indo,!Oceanic! 42! EAI6! 2! 239! 66!
1.2! Indo,!Oceanic! 39! EAI1,!EAI2! 9! 239! 5!
1.2.1! Indo,!Oceanic! 11! EAI2! 5! 239! 87!
1.2.2! Indo,!Oceanic! 28! EAI1! 4! 239! 95!
2! East,!Asian! 388! Beijing! 14! None! 106!
2.1! East,!Asian! 4! Orphan!and!Manu!
ancestor!
3! None! 245!
2.2! East,!Asian! 386! Beijing! 13! 105,!207! 123!
2.2.1! East,!Asian! 376! Beijing! 13! 105,!207,!181! 33!
2.2.1.1! East,!Asian! 16! Beijing! 4! 105,!207,!181,!
150!
25!
2.2.1.2! East,!Asian! 2! Beijing! 2! 105,!207,!181,!
142!
53!
2.2.2! East,!Asian! 10! Beijing! 3! 105,!207! 80!
3! East,!African,!
Indian!
189! CAS! 18! 750! 262!
3.1! East,!African,!
Indian!
121! NonGCAS1,!Delhi! 7! 750! 1!
3.1.1! East,!African,!
Indian!
102! CAS1,!Kili! 5! 750! 101!
3.1.2! East,!African,!
Indian!
17! CAS2,!CAS! 3! 750! 14!
3.1.2.1! East,!African,!
Indian!
10! CAS2! 3! 750! 24!
3.1.2.2! East,!African,!
Indian!
7! CAS! 1! 750! 188!
4! Euro,!American! 856! S,!T,!X,!LAM,!H! 22! None! 114!
4.1! Euro,!American! 226! T,!H,!X!families! 14! None! 81!
4.1.1! Euro,!American!(X,!
type)!
138! X!family! 8! None! 35!
4.1.1.1! Euro,!American!(X,!
type)!
47! X2! 3! 183! 59!
4.1.1.2! Euro,!American!(X,!
type)!
20! X1! 2! None! 85!
4.1.1.3! Euro,!American!(X,!
type)!
69! X3,!X1! 6! 193! 106!
4.1.2! Euro,!American! 77! T1,!H1! 9! None! 17!
4.1.2.1! Euro,!American!
(Haarlem)!
63! T1,!H1! 9! 182! 87!





26! H3,!H4! 2! None! 43!
4.2.2! Euro,!American! 28! LAM7,!TUR,!T1! 6! None! 34!
4.2.2.1! Euro,!American!
(TUR)!
11! LAM7,!TUR! 2! None! 97!





9! LAM9! 2! None! 92!
4.3.2! Euro,!American!
(LAM)!
24! LAM3! 3! None! 102!
4.3.2.1! Euro,!American!
(LAM)!
4! LAM3! 1! 761! 70!
4.3.3! Euro,!American!
(LAM)!


















142! LAM11,!ZWE! 5! 174! 18!
4.4! Euro,!American! 40! S,!T1,!T2! 7! None! 54!
4.4.1! Euro,!American! 22! S,!T1! 5! None! 52!
4.4.1.1! Euro,!American!(S,!
type)!
11! S! 4! None! 81!
4.4.1.2! Euro,!American! 11! T1! 3! None! 119!
4.4.2! Euro,!American! 18! T1,!T2! 3! None! 114!
4.5! Euro,!American! 24! H3,!H4,!T1! 3! 122! 143!
4.6! Euro,!American! 26! LAM10,!CAM,!T2! 6! None! 16!
4.6.1! Euro,!American!
(Uganda)!
16! T2,!Uganda,!T2! 3! 724! 108!
4.6.1.1! Euro,!American! 3! T2,!Uganda! 1! 724! 67!
4.6.1.2! Euro,!American! 13! T2! 3! 724! 64!
4.6.2! Euro,!American! 10! LAM10,!CAM,!!T3! 3! 726! 52!
4.6.2.1! Euro,!American! 2! T3! 1! 726! 230!
4.6.2.2! Euro,!American!
(Cameroon)!
8! LAM10,!CAM! 3! 726! 144!
4.7! Euro,!American!
(mainly!T)!
6! T1,!T5! 2! None! 11!
4.8! Euro,!American!
(mainly!T)!
142! T1,!T2,!T3,!T4,!T5! 11! 219! 25!
4.9! Euro,!American!
(mainly!T)!
32! T1! 4! None! 88!
5! West,!Africa!1! 17! AFRI_2,!AFRI_3! 5! 711! 372!
6! West,!Africa!2! 11! AFRI_1! 4! 702! 220!














From! the! 91,648! SNPs,! 6,915! lineage! and! subGlineage! informative! markers! were!
identified! (list! available! in! http://pathogenseq.lshtm.ac.uk/tbmolecularbarcodedata).!
The!distribution!of!functional!categories!of!genes!containing!the!91,648!and!6,915!SNP!
sets! did! not! differ! (Figure! 3.5A).! Using! the! informative! SNPs! (n=6,915),! there! was!
evidence! of! difference! in! the! distribution! of! functional! categories! between! lineages,!
namely! a! greater! proportion! of! lipid! metabolism! nonGsynonymous! polymorphism! in!
lineage! 2! (Figure! 3.5A),! ! consistent! with! the! greater! virulence! of! the! Beijing! strain!





Robust! SNPs! in! essential! genes!with!mutations! that! lead! to! synonymous! amino! acid!
changes!were!chosen!(n=413,!6%),!therefore!less!likely!to!be!under!selective!pressure.!
Redundancy!of!markers!was!observed!for!most!of!the!clades,!and!one!representative!
per! group! was! randomly! selected,! leading! to! a! minimum! set! of! 62! SNPs! for! MTBC!
classification!(Supplementary!Table!4).!ReGconstruction!of!a!phylogenetic!tree!using!the!




(A)!Summary!of! functional! categories! for!3! sets!of!SNPs:!all! (n=91648,! left),! lineage,! specific! (LSGSNPs)!









To! validate! the! proposed! SNP! classification! system,! it! was! applied! to! 27! complete!
reference!genomes!representing!all!MTBC!lineages!and!M.#bovis,!when!it!was!found!to!
predict! 100%! their! reported! strainGtypes! (Supplementary! Table! 5).! Furthermore,! the!
scheme! was! used! to! classify! 850! samples! from! Samara,! Russia,! not! included! in! the!
1601!samples,!and! found! the!same!reported! lineage!proportions! (Casali!et#al.!2014).!
More!importantly,!unclassified!samples!from!lineage!4!in!this!study!could!be!assigned!




Filliol45! ! (45! SNPs! (Filliol! et# al.! 2006)),! Comas93! (93! SNPs! (Comas! et# al.! 2009))! and!
Homolka71! (71! SNPs! (Homolka! et# al.! 2012)).! The! proportion! of! these! SNPs! found!
among! the! phylogenetic! informative! sets! differed! (Filliol45! 29%;! Comas93! 76%;!
Homolka71! 49%)! and! some! of! them!were! nonGsegregating! across! the! 1601! samples!
(Filliol45! 17.8%,! Comas93! 4.3%;! Homolka71! 39.0%)! indicating! limitations! in! their!
variant! and! sample! ascertainment.! Comas93! and! Homolka71! sets! unambiguously!
separated!the!six!of!the!seven!main!MTBC!lineages!and!the!resolved!subGlineages!were!
largely!compatible!with!the!ones!described!in!this!study!(Table!3.4).!Still,!not!all!known!
RD! subGlineages! (Gagneux! et# al.! 2006),! particularly! for! lineage! 4,! could! be! resolved!
using!these!classification!systems.!Phylogenetic!trees!constructed!for!the!1601!samples!
! 87! !
using! these! SNP! sets! (Supplementary! Figure! 5,! Supplementary! Figure! 6! and!
Supplementary!Figure!7)!highlighted!the!lack!of!resolution!at!the!subGlineage!level.!The!
proposed! set! of! 62! SNPs! are! informative! for! all! 7!main!MTBC! lineages,! indicating! at!
least! parity! in! performance! with! RD! typing.! Further,! the! superior! number! of! subG










if! certain! strain! types! exhibit! more! virulent! phenotypes! than! others.! From! an!
epidemiological! point! of! view,! robust,! reproducible! and! highly! discriminatory! typing!



































































































homoplasy,! namely! unrelated! strains! being! clustered! together! due! to! convergent!
evolution! of! their! genotyping! markers,! became! apparent.! SNPs! and! other! genetic!







between! experimental! and! highGthroughput! sequencing.! SpolPred! achieved! high!
prediction! accuracy! in! the! validating! dataset;! in# silico! derived! spoligotypes!matched!
the! experimental! ones! for! 39! out! of! 44! samples.! Furthermore,! the! newly! assigned!
spoligotypes!for!samples!with!unknown!experimental!spoligotype!were!clustered!with!
other! isolates!having! coincident!experimental! and! in# silico! predicted! lineages! (Figure!
3.3).! Interestingly,! the!absent! sequence! spacer! responsible! for! the! few!discrepancies!
observed,! namely! spacer! 15,! was! the! same! across! all! five! problematic! isolates.! The!
ambiguous! distinction! of! this! spacer! has! already! been! reported! (Abadia!et# al.! 2011)!
and! explained! in! terms! of! the! presence! of! a! 4Gnt! deletion! adjacent! to! the! amplified!
sequence! (van! Embden! et# al.! 2000),! which! would! not! allow! a! proper! primer!
! 89! !
hybridization.!Other!ambiguities!caused!by!the!insertion!of!IS6110!copies!in!the!direct!
repeat! region!have!also!been! reported! (Filliol! 2000).! These! results! demonstrate! that!
SpolPred# can! be! employed! to! accurately! and! quickly! confirm! experimentally!
determined!spoligotypes,!infer!them!from!sequenced!isolates!with!no!laboratory!data!
(Rashdi!&!Jadhav!2014)!and!reveal!unexpected!cases!of!wrongly!assigned!types.!Other!
causes! of! TB! misclassification! such! as! laboratory! cross! contamination,! PCR!
contamination!or!ambiguous!hybridization!patterns!could!also!be!clarified.!
In!order!to!characterise!genomeGwide!strain!specific!markers,!a!genomic!analysis!was!
performed! on! a! global! collection! of! 1,601!MTBC! isolates.! A! highGresolution! map! of!
polymorphisms! consisting! of! more! than! ninety! thousand! SNPs! was! derived.! This!
genomic!variation!was!used! to! infer!phylogenetic! relationships!both! interG!and! intraG
lineage! to! an! unprecedented! level! of! resolution,! and! led! to! the! development! of! an!
extendable!nomenclature! for! subGlineages.!All! known!main!MTBC! lineages,! including!
the!recently!discovered! lineage!7,!and!subGlineages!could!be! identified!by! integrating!
spoligotype! and!RD! information!with! the! SNPGbased! phylogeny.! This!way! the! herein!
described! groups! can! be! linked! to! known! RD! and/or! spoligotype! lineages! described!
elsewhere! (Table!3.3).!An!extensive! repertoire!of! 7k! lineage!and! subGlineage! specific!




markers! can! be! used! to! construct! highGresolution! and! reproducible! phylogenies,! be!
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incorporated! in! diagnostic! assays! and! assess! genotypeGphenotype! associations.! This!
new! genomeGwide! SNPGtyping! system! entails! an! advance! with! respect! to! previous!
molecular!barcodes!for!MTBC.!These!systems!are!limited!due!to!the!small!number!of!
genes! studied! (Homolka! et# al.! 2012)! or! small! sample! sizes! consisting! of! groups! of!
related! strains! used! in! their! construction! (Filliol! et# al.! 2006).! The! SNPGbased!
phylogenetic! tree! had! higher! resolution,! and! resolved! 33! subGlineages! within! the!
historically! poorly! characterised! EuroGAmerican! lineage,! and! added! further!
discrimination!within!EAI!and!CAS! lineages.!There!was!a!high!degree!of!compatibility!
with!this!approach!and!the!“gold!standard”!RD!MTBC!classification!system!(Gagneux!et#
al.! 2006)! at! the! lineage! and! subGlineage! level! (e.g.! Haarlem! group,! lineage! 2.1.2.1,!
RD182;! T! strains,! lineage! 4.8,! RD115).! However,! the! RD! system! is! incomplete.! RDG
defined! clades! (e.g.! RD174)! harboured! multiple! SNPGdefined! groups! demonstrating!
that! although! phylogenetically! robust,! LSPs! lack! resolution.! Similarly,! some! SNPG




The! integration! of! spoligotype! and! RD! data! improved! the! positioning! of! traditional!
strain! types! (e.g.! Haarlem,! LAM)! into! SNPGdefined! subGlineages! within! the! global!
phylogeny.!




to! incorporate! novel! strain! types! should! they! be! reported.! The! usefulness! of! the!
barcode,!as!an!important!tool!for!TB!control!and!elimination!activities!worldwide,!will!
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The!usefulness!of!WGS! for!accurate!and!highly!discriminatory!strain! typing! in!TB!has!
been! repeatedly! proved! in! recent! reports! (Comas! et# al.! 2009;! Roetzer! et# al.! 2013;!
Bryant,!Harris,!et#al.!2013)!and! is! reinforced!by!the!results!presented! in!the!previous!






Resistance! has! been! reported! to! all! drugs! used! to! treat! TB! (Dheda! et# al.! 2014).!
Increased!resistance!is!associated!with!decreased!patient!survival!and!the!emergence!
of! resistance! to! first!and! second! line!drugs! is!a! substantial! threat! to!disease!control.!
The!WHO!classifies!TB!resistant!to!INH!and!RMP,!the!two!key!first0line!anti0TB!drugs,!as!
multi! drug0resistant! (MDR0TB),! and! a! switch! to! second! line! treatment! is! advised.!
Resistance! to! additional! drugs! such! as! EMB,! or! STR! further! compromises! treatment!
(Tahaoğlu!et#al.!2001;!Migliori!et#al.!2009).!MDR!strains!that!have!developed!resistance!
to! the! FLQ! and! AMI! used! in! second! line! treatment! are! classed! as! extensively! drug!
resistant!(XDR0TB).!The!term!total!drug!resistance!(TDR0TB)!has!been!used!to!describe!
strains!found!resistant!to!all!drugs!for!which!tests!are!available,!but!there!is!not!yet!an!
agreed! definition! of! TDR0TB! (Dheda! et# al.! 2014).! Treatment! of! these! forms! of! DR!
! 94! !
disease! is! difficult! and! expensive,! and! outcomes! are! poor! (Pooran! et# al.! 2013;!
Abubakar!et#al.!2013;!Lange!et#al.!2014).!Treatment!is! long,! in!some!cases!years,!and!





The! primary! cause! of! resistance! in!Mtb! is! the! accumulation! of! point!mutations! and!
indels!in!genes!coding!for!drug0targets!or!drug0converting!enzymes.!INH!is!a!pro0drug!
activated!by!the!catalase0peroxidase!enzyme!KatG.!!The!active!form!of!this!drug!blocks!
the! substrate! of! InhA,! an! enzyme! involved! in! mycolic! acid! biosynthesis,! essential!
components!of! the!mycobacterial! cell!wall,! leading! to! the!disruption!of! the! cell!wall!
and! resulting! in!a! loss!of!cellular! integrity.!Altered!or!diminished!catalase0peroxidase!
activity!caused!by!nsSNPs! in!katG! is! the!most! frequent!mechanism!of! INH!resistance!





An! alternative! genetic! strategy! by! Mtb# to! diminish! INH! interference! consists! in!
mutations! in! the! binding! site! of! InhA! or! over0expression! of! this! enzyme! by! point!




loci! such! as! ahpC! and! kasA! have! also! been! linked! to! INHR.! The! former! gene! is! co0
expressed!with!katG!in!response!to!oxidative!stress.!It!is!not!clear!though!whether!an!
increased! expression! of! ahpC! is! a! consequence! of! the! loss! of! functional! katG,! i.e.!
compensatory!mutations,!or!a!cause!of!resistance.!Similarly,! it! is!unclear!whether!the!
KasA!enzyme!involved!in!mycolic!acid!synthesis!is!also!a!direct!target!of!activated!INH!




In! contrast! to! the!multiple! reported!mechanisms! of! INHR,! RMP! resistance! (RMPR)! is!
determined! by! mutations! in! the! rpoB# gene.! RMP! and! other! rifamycins! have! high!
affinity!to!the!RNA!polymerase!encoded!by!rpoB!and!rpoC! in!Mtb.!While!nsSNPs!and!
indels! in! the!coding! region!of! rpoB,!mostly! in! the!810bp!RMP! resistance0determining!
region! (RRDR),! are! the! main! cause! of! RMPR,! compensatory! mutations! in! the! rpoC#
originate!to!restore!the!fitness!cost!caused!by!rpoB!mutations!(de!Vos!et#al.!2013).!
The! genetic! causes! of! resistance! to! other! first0line! drugs! are! not! fully! characterised.!
STR!is!known!to!inhibit!protein!synthesis!by!interfering!in!the!small!30S!subunit!of!the!
ribosome,! precisely! in! the! 16S! ribosomal! RNA! encoded! by# rrs! gene! and! the! S12!
ribosomal!protein!encoded!by#rpsL!gene!in!Mtb.!Mutations!in!the#rrs!gene!have!been!
linked!to!intermediate!levels!of!resistance!and!account!for!20%!of!STR0resistant!strains.!
rpsL! mutations! are! generally! associated! with! high! levels! of! STR! resistance! and! are!









mechanisms! of! resistance! are! currently! characterised! as! PZAR! clinical! strains! lacking!




date.!Mutations! in! the! embCAB!operon,!which! encodes! for! enzymes! involved! in! the!
biosynthesis! of! arabinan! components! of!mycobacterial! cell! wall,! are! responsible! for!
EMB! resistance! (EMBR)! (Telenti! et# al.! 1997).! However,! many! clinical! strains! have!
mutations! in!these!genes!while!remaining!susceptible!to!EMB.! It! is!becoming!evident!
that!EMBR!develops!through!mutations!in!multiple!loci,!including!embA/B/C!genes!and!
other! currently! unknown! genes,! resulting! in! a! range! of! different! levels! of! resistance!
(Safi!et#al.!2013).!
Ethionamide! (ETH)! is! a! second0line!anti0TB!drug! indicated! to! treat!MDR0TB.! Like! INH!
and!PZA,!ETH!is!a!pro0drug!that!needs!to!be!activated,!in!this!case!by!the!EthA!enzyme!
(Baulard! et# al.! 2000),! whose! expression! is! negatively! regulated! by! EthR,! a!
transcriptional! repressor! that! interacts! directly! with! the! ethA! promoter! region!
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(Engohang0Ndong!et#al.!2003).!ETH!is!a!structural!analogue!of!INH!and!shares!the!same!





EthR!transcriptional! regulator! (Engohang0Ndong!et#al.!2003).!Mutations! in!these!four!




consists! of! two! sub0units! encoded! by! gyrA! and! gyrB! genes! (Takiff! et# al.! 1994).!
Resistance! to! FLQ! arises! from! mutations! in! the! quinolone! resistance0determining!
region!(QRDR)!located!within!gyrA!and!gyrB.!In!most!of!studies,!more!than!90%!of!FLQ0
resistant! strains! have!mutations! in! the! QRDR! (Maruri! et# al.! 2012).! QRDR!mutations!
confer! cross0resistance! within! the! FLQ,! albeit! not! at! the! same! level.! For! the! same!
mutations,! moxifloxacin! (MOX)! normally! presents! the! lowest! minimum! inhibitory!
concentration! (MIC)! values! in! the! group! followed! by! levofloxacin! (LEVO),! and! in!
contrast! with! the! higher! levels! of! resistance! observed! for! ofloxacin! (OFX)! and!




AMI!drugs!kanamycin! (KAN),! capreomycin! (CAP)!and!amikacin! (AMK)!are!second0line!
injectable!antibiotics!used!to!treat!MDR0TB.!AMI!are!ribosome0binding!antibiotics!that!
target! the! 16S! rRNA! encoded! by# rrs! gene.! Mutations! in! the! 1,4000bp! region! of# rrs!
confer!cross0resistance!to!all!AMI!members!albeit!not!at!the!same!level.!Mutations!in!
the! eis! promoter! region! have! been! associated! with! KAN! resistance.! Additionally,!
mutations! located! throughout! the! whole! tlyA# gene! are! only! associated! with! CAP!
resistance.!!
4.1.3 Available#diagnostic#tests#for#drug#resistant#tuberculosis#
Early! detection! of! DR! is! crucial! for! access! to! effective! treatment! and! prevention! of!
onward! transmission.! Knowledge! of! the! full! drug! susceptibility! profile!would! enable!
tailored!treatment!to!improve!efficacy!and!reduce!exposure!to!ineffective!toxic!drugs.!
Current! testing! for! resistance! to!most!anti0TB!drugs! involves! isolation!and! culture!of!
the!bacteria!followed!by!exposure!to!the!drug,!a!process!that!takes!weeks!or!months!
and! requires! high! levels! of! microbiological! safety.! Rapid! molecular! assays! are! now!
available! for! some! key! drugs! that! test! directly! from! sputum! and! in! 2013! the! Xpert!














range! of! anti0TB! drugs.! Sequencing! technologies! are! evolving! rapidly! and! benchtop!
analyzers! have! been! developed! capable! of! sequencing! a! bacterial! genome! in! a! few!
hours.! Costs! have! been! greatly! reduced! with! the! introduction! of! high! throughput!




restricted! whole! genome! analysis! to! the! research! laboratory.! Recent! reports! of!
sequencing!M.#tuberculosis!from!sputum!from!suspected!XDR0TB!patients!suggest!this!
will! soon! change.! However,! data! analysis! remains! a! bottleneck,! requiring! specialist!




whole! genome! sequence! data! from! clinical! isolates,! compared! to! their! phenotype!
obtained! by! conventional! DST.! To! assess! the! potential! benefits! of! a! whole! genome!







(see! list! in! http://pathogenseq.lshtm.ac.uk/rapiddrdata).! Drugs! included! were! AMK,!
CAP,!EMB,!ETH,!INH,!KAN,!MOX,!OFX,!PZA,!RMP!and!STR.!



































First! of! all,! two! databases! were! consulted,! TBDreaMDB! (Sandgren! et# al.! 2009)! and!
MUBII/TB/DB! (Flandrois! et# al.! 2014).! Lineage! specific! mutations! and! polymorphisms!
without! sound! phenotypic! data! supporting! their! association! with! resistance! were!
discarded.! In! addition,! recent! literature!was! consulted! to! extract! new!DR!mutations!
from! review! papers! (Nebenzahl0Guimaraes! et# al.! 2014;! Laurenzo! &! Mousa! 2011;!
Maruri! et# al.! 2012;! Georghiou! et# al.! 2012),! papers! on! TB! DR! tests! (Liu! et# al.! 2013;!
Moure!et#al.!2013;!Shi!et#al.!2013;!Wang!et#al.!2013;!Zimenkov!et#al.!2013;!Sekiguchi!et#
al.! 2007;! Engström!et# al.! 2012;!Helb!et# al.! 2010;! Jin!et# al.! 2012;!Ajbani!et# al.! 2012),!
papers!on!gene!mechanisms!of!DR!(Slayden!&!Barry!2000;!Jagielski!&!Grzeszczuk!2013;!
Ando!et#al.! 2010;! Safi!et#al.! 2013;!Morlock!&!Metchock!2003;!DeBarber!et#al.! 2000;!
Brossier!et#al.! 2011;!Tan!et#al.! 2013)!and!other! recent! studies! (H.!Zhang!et#al.! 2013;!
Boonaiam!et#al.!2010;!Jnawali!et#al.!2013;!Lin!et#al.!2013).!As!presented!in!Table!4.1,!
the!library!comprised!1276!polymorphisms!at!946!nucleotide!positions!from!25!loci,!6!
promoters! and! 19! coding! regions,! involved! in! resistance! to! 11! drugs.! In! addition! to!
examining! individual!drugs! the!cumulative! loci! for!MDR!and!XDR0TB!was!considered.!
Circos! software! was! used! to! construct! circular! genomic! region! variation! maps!
(Krzywinski!et#al.!2009).!The!R!software!package!was!used!for!statistical!analysis.!
4.2.2 Sequence#data#and#drug#susceptibility#testing#
The! precision! of! the! curated! library! for! predicting! resistance! was! assessed! through!
analysis! of! new! and! published! sequence! data! so! that! in# silico! inferred! resistance!
phenotypes! could! be! compared! to! phenotypes! derived! from! conventional! culture0
based! susceptibility! studies.! Only! sample! collections! with! raw! sequencing! data!
(minimum! read! length! 50bp)! and! drug! susceptibility! data! from! recognized! testing!
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protocols!(Stop!TB!Partnership!2014)!were!considered.!A!total!of!792!isolates!from!six!




samples!were! reported! and! 99.2%! of! RMP! resistant! samples!were!MDR0TB.! In# silico!
genotyping! using! SpolPred! (Section! 3.2.2)! revealed! all!major!modern!MTBC! lineages!
were! represented,! including! Lineage! 1! (EAI! family,! n=68,! 8.6! %),! Lineage! 2! (Beijing,!
n=182,! 23!%),! Lineage!3! (CAS,! n=86,! 10.9!%)! and! Lineage!4! (456! isolates,! 57.5!%,! of!
which!35!X,!97!T,!298!LAM,!4!S,!18!H,!4!other).!Where!conventional!susceptibility!data!
was! not! available! samples! were! excluded! from! analysis! for! that! drug.! Sensitivity,!
specificity,! accuracy,! 95%! confidence! intervals! (CI)! for! the! statistical! performance! of!
each! test! (i.e.!DR!mutation! list)!were!estimated!using! the! following! formula! (Altman!
1990):!
!"#$%&%'%&(! = !"!" + !"!
!"#$%&%$%'(! = !"!" + !"!
!!""#$%"& = !" + !"!" + !" + !" + !!"!
where! TP# represents! the! number! of! true! positives! (phenotypic! resistant! isolates!
harbouring!DR!mutations),!FN'false!negatives!(phenotypic!resistant!isolates!lacking!DR!





!" = ! ± !! !(!!!)!     
where!p!is!either!sensitivity!or!specificity,!z!is!equal!to!1.96!and!n!is!the!denominator!in!
either!the!sensitivity!(n'=!TP'+'FN)!or!specificity!(n'=!TN'+'FP)!formulas.!
To!compare!the!performance!of!a!pair!of!genotypic! tests! (i.e.!DR!mutation! lists),! the!
difference! between! the! underlying! discordant! results! (i.e.! number! of! samples! being!
positive!for!test!1!and!negative!for!test!2!(b)!versus!negative!for!test!1!and!positive!for!
test!2!(c))!was!calculated.!The!statistical!significance!of!this!difference!was!determined!
using! the! common! proportion! difference! test! for! binomial! variables! based! on! the!
following!p0value:!
!!"#$% = 2 1− !"#$% ! − !! + ! !




mapped! to! a! modified! version! of! the! H37Rv! reference! genome! using! the! Snap#























To! examine! the! potential! analytical! advantage! of! WGS! over! current! molecular!
technology! for! detecting!DR,! comparison!was!made!with! three! commercial! tests:! (i)!
the!Xpert!MTB/RIF! (Cepheid! Inc,!USA)!which!targets! the!rpoB!gene! for!RMPR;! (ii)! the!
LiPA!MTBDRplus#for!MDR0TB!(Hain!Lifescience,!Germany)!which#targets!rpoB,!katG!and!
inhA! for! resistance! to! RMP! and! INH! and# (iii)! the! LiPA! MTBDRsl! (Hain! Lifescience,!
Germany)!which! targets!gyrA,! rrs!and!embB! for! resistance! to! the!FLQ,!AMI!and!EMB!
respectively.!Using!the!polymorphisms!exploited!within!these!assays!(Helb!et#al.!2010;!
Jin! et# al.! 2012;! Ajbani! et# al.! 2012),! in# silico! versions! were! developed,! and! their!








The!mutation! library!was! validated! using! new!and!publically! available! sequence! and!
phenotypic! data.! In# silico# inferred! resistance! from!WGS! data! was! compared! to! the!






to! RMP! and! INH,! respectively.! Of! the! 22! INH! resistant! samples! predicted! as!
susceptible,! 14!were! from!China,! 7! of! those! had!mutations! in! known! candidate! loci!


















































































































































































certain! region! (e.g.! rpoB).! Vertical! black! lines! indicate! the! frequency! of! mutations! observed! in!










Correlation! was! lower! for! other! first! line! drugs.! For! PZA,! 32! of! 110! samples! with! a!
resistant!phenotype!harboured!no!mutations! in! known!DR!genes,! including!18!of!37!






and! KAN! (87.3/93.4%)! than! for! CAP,! where! 35! of! 89! resistant! samples! were! not!
detected! by! the! in# silico! genome! analysis.! Testing! for! FLQ! resistance! was! less!
commonly! reported! and! data! for! OFX! was! restricted! to! two! studies! (China! and!
Portugal)!with!a!total!of!313!samples!tested.!
Ten!OFX0susceptible! samples!were! found! to! harbour!mutations! associated!with! FLQ!
resistance! (94.4%! specificity),! and! mutations! were! not! identified! in! 17! resistant!
samples! (85.5%!sensitivity).!Of!42! samples! tested! for! susceptibility! to!MOX,!10!were!
reported! as! phenotypically! resistant,! of! which! 6! were! recognized! by! the! in# silico!
mutation!analysis!(60%!sensitivity).!Figure!4.3!summarises!the!mutations!and!multiple!
loci!associated!with! resistance! to! INH,!RMP,!FLQ!and!AMI!and!shows! those! found! in!
phenotypically! determined! XDR! cases.! Supplementary! Figure! 8! illustrates! the! loci!
involved! in! resistance! to! each! of! the! 11! drugs,! the! position! of! DR!mutations! in! the!
curated!list!within!these!loci,!and!DR!mutations!observed!in!phenotypically!resistance!
cases.! The! cumulative! effect! of! these!DR!mutations! on! sensitivity! and! specificity! for!
each!drug!is!shown!in!Supplementary!Figure!9.!!
4.3.2 Comparison#with#commercial#tests#
Having! assessed! the! diagnostic! potential! of! the! mutation! library! comparisons! were!
made! with! polymorphisms! used! in! commercial! molecular! tests! for! DR.! Results! are!
summarised! in! Figure! 4.4.! When! screening! for! resistance! to! RMP! there! was! no!










For! each! library,! in# silico# inferred! resistance! phenotypes! were! compared! to! reported! phenotypes!





The!mutations! concerned!were!mainly! in! the! katG# gene:! S315N! (n=9),! S315G! (n=1),!
D419H!(n=1),!L378P!(n=1),!V1A!(n=1),!Y155C!(n=3),!W191R!(n=5!and!always!with!C015T!
inhA#promoter),!N138D!(n=1,!with!T08A! inhA!promoter)!and!T380I! (n!=!1,!with!C015T!
inhA# promoter).! There! were! also! 6! samples! with! ahpC! promoter! mutations! and! 2!
samples! with! inhA! mutations! (S94A! and! I194T).! No! resistance! mutations! were!
observed!in!INH!susceptible!strains!(i.e.!100%!specificity).!
The! curated! library! offered! enhanced! accuracy! over! the! line! probe!mutations!when!
screening! for!MDR0TB! (95.8! vs.! 93.1!%;! p<0.00042).!Detection!of! resistance! to! EMB,!
OFX,! AMK! and! KAN! was! also! enhanced! by! the! whole! genome! analysis.! A! slight!
reduction!in!specificity!was!observed!for!five!drugs:!EMB!(91.6!vs.!74.6%,!p<1.54e008),!





(60.7%! in!both! cases)! and!KAN! (87.3! vs.! 56.8%,!p<1.97e009).!Overall!when!detecting!
XDR0TB! resistant! cases! the! curated!mutation! library!offered!enhanced!accuracy!over!
the!line!probe!mutations!(96.3!vs!93.7%;!p<0.0047)!(Figure!4.4).!
4.3.3 Comparison#with#other#drug#resistance#databases#
The! diagnostic! accuracy! of! other! DR! mutation! databases,! namely! TBDreaMDB!


















Slightly! more! INH! resistant! cases! could! be! correctly! assigned! (283/305,! 92.8%!
sensitivity)! than! MUBII/TB/DB! (276/305,! 90.5%! sensitivity)! without! compromising!




Of! 110! PZA! resistant! samples,! 78! (70.9%! sensitivity)!were! detected! compared! to! 50!
(45.5%)!and!64!(58.2%)!identified!by!MUBII/TB/DB!and!TBDreaMDB!respectively.!While!
specificity!was!relatively!high! for!both!ETH!(93.3%)!and!PZA!(93.9%),!not!all! resistant!
cases! were! found! to! harbour! mutations! in! known! genes! (51! and! 25! respectively).!
Resistant!clinical! isolates! lacking!mutations! in!candidate!genes!have!been!extensively!
reported! for! both! ETH! (Brossier! et# al.! 2011)! and! PZA! (Stoffels! et# al.! 2012a).! STR!
specificity!by!TBDreaMDB#was!significantly!low!(40.8%)!due!to!the!presence!of!lineage0
specific!SNPs!in!the!gid#gene!(e.g.!E92D!for!Modern!Beijing!and!L16R!for!LAM),!which!
were! found! in!both! STR! susceptible! and! resistant! cases! and! therefore!unlikely! to!be!
involved!in!STR!resistance.!!
Both!MUBII/TB/DB!and!the!curated!library!produced!similar!predictive!performance!for!
most! of! second! line! drugs! (OFX,! MOX,! AMK! and! CAP).! TBDreaMDB# reports! several!
mutations!(E21Q,!G668D!and!S95T! in!gyrA)!that!do!not!correlate!with!FLQ!resistance!
and! were! responsible! for! the! very! low! specificity! for! FLQ! resistance! (Maruri! et# al.!
2012).!By! including!mutations!at!the!eis#promoter,!103!of!118!KAN!resistant!samples!
were! identified! (87.3%!sensitivity)! compared! to!67! (56.8%)!and!77! (65.2%)!predicted!
by! TBDreaMDB! and! MUBII/TB/DB! respectively.! Overall,! the! presented! database!
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tool! to! rapidly! identify! a! DST! and! strain0type! profile! was! developed.! In! addition,! to!














































the! reference! amino! acid,! codon! number! and! alternative! amino! acid.! SNPs! in! non0coding!
regions! and! indels! are! annotated! using! the! reference! nucleotide! allele,! chromosome!
coordinate!and!alternative!allele!as!extracted!from!the!VCFs.!!
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This!approach!called!TB#profiler! aligns! raw!sequencing!data! to!a! small!version!of! the!
Mtb! reference! genome,! consisting! of! 4%! of! the! original! chromosome! size! and!
containing! only! DR! candidate! loci! and! regions! harbouring! strain0specific! SNPs.! TB#
profiler! processed! FASTQ! files! at! a! rate! of! 80,000! sequence! reads! per! second.!
Application! to! the! 792! samples! led! to! the! identification! of! 36! novel! mutations! (24!
nsSNPs,!9! indels!and!5!intergenic!SNPs)! in!phenotypically!resistant!strains!and!absent!
in! susceptible! ones,! which! could! be! potentially! driving! resistance! (Table! 4.3).! The!
online!tool!is!available!from!http://tbdr.lshtm.ac.uk/!(Figure!4.1).!
4.4 DISCUSSION#
The!global!emergence!and!amplification!of! resistance! to!anti0TB!drugs!has! created!a!
need!for!improved!detection!tools.!Conventional!DST,!which!in!this!work!is!assumed!to!
be! the!reference!standard,! requires!several!weeks! to!complete!and!variation! in!both!
protocols!and!MIC!standardization!can!lead!to!inconsistent!results.!Therefore,!point0of0
care! diagnostic! tests! for! rapid! detection! of! all! available! anti0TB! drugs! are! urgently!
needed!to!guide!treatment!options!for!patients!with!MDR,!XDR0TB!and!post!XDR!(TDR0
TB)!disease.!!The!potential!of!WGS!to!provide!such!a!solution!was!assessed.!A!library!of!








and! is! fully!understood!compared!other!TB!drugs! that!have!more!complex!modes!of!
action.!Unsurprisingly!the!sensitivity!was! lower!for!drugs! like!PZA!and!ETH,!for!which!
the!understanding!of!the!genetic!basis!of!resistance!is!currently!incomplete!(Brossier!et#
al.! 2011;! Stoffels! et# al.! 2012a).! Further! work! is! needed! to! determine! additional!
polymorphisms!predictive!of!resistance!to!these!drugs.!As!illustrated!in!Figure!4.2!and!
Figure!4.3!a!large!number!of!loci!are!associated!with!MDR!and!XDR.!
A! limiting! factor! for! this! study! is! the! reliability!of! culture0based! susceptibility! testing!
methods!and!the! lack!of!a!gold!standard!with!which!to!compare!new!tests.!Previous!
studies! on! discrepancies! between!mutation! and! culture! derived! phenotypes! suggest!
that!molecular!assessment!may!eventually!become!the!gold!standard!for!some!drugs!
(Rigouts!et#al.!2013;!Van!Deun!et#al.!2013).!
In! addition! to! assessing! additional! numbers! of! drugs,! the! sensitivity! of! the! whole!
genome! mutation! library! was! equal! to,! or! greater! than! the! mutations! used! in! the!




of!mutations!with!weak!or!no! supporting!data,!mainly! strain0specific!mutations.! The!
enhanced! sensitivity!was!greatest! for! INH,!KAN!and! for!MDR!and!XDR0TB.! Specificity!
for! RMP,! INH,! AMK,! MDR! and! XDR0TB! exceeded! 98%.! Results! for! EMB! were! less!
promising!as!although!a!sensitivity!of!88.5%!was!achieved,! the!specificity!of!71.3%! is!
inadequate.! These! results! are! in! line! with! different! levels! of! EMB! resistance! being!
acquired! through! mutations! in! multiple! loci,! some! of! which! are! currently! unknown!
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(Safi! et# al.! 2013).! Although! the! current! state! of! knowledge! does! not! allow! EMB!
resistance!to!be!predicted!at!high!precision,!EMB!resistant!mutation!in!the!curated!list!
can! be! helpful! at! pointing! to! strains! with! higher! predisposition! to! develop! such!
resistance.!It!should!be!noted!that!high!positive!predictive!value!is!crucial!for!DR!tests!
where! the!consequence!of!a! false!positive!may!be!unnecessary! isolation! in!specialist!
containment!facilities!and!prolonged!treatment!with!drugs!of!increased!toxicity.!!
The! accuracy! of! the! mutation! analysis! was! observed! to! vary! by! geographic! region!
(Supplementary!Figure!10).!The!isolates!used!in!this!dataset!(WGS!data!set!3)!were!not!











explain! its! lower! specificity.! Strains! having! the! same! FLQ! resistance0conferring!
mutations! are! more! likely! to! be! regarded! as! sensitive! (false! positives)! for! MOX.!
Sensitivity! for! MOX! also! needs! to! be! improved! (60%).! The! low! number! of! MOX0
resistant! cases! (n=10)! may! be! biasing! the! calculated! sensitivity.! Similarly,! CAP!
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specificity!was!lower!than!AMK!(90.7!vs.!98.3%)!and!KAN!(90.7%!vs.!93.4%).!24!of!the!
269! CAP0susceptible! strains! had! the! A1401G! rrs# SNP,! a! frequently! reported! AMI0
resistance!conferring!mutation,!also!found!in!50/89!CAP0resistant!samples.!The!finding!
of!AMI0resistant!mutations!in!CAP0susceptible!samples!(i.e.!low!specificity)!has!already!
been! observed! and! explained! in! terms! of! a! high! MIC! cut0off! recommended! by! the!
WHO!for!CAP!(Rodwell!et#al.!2013).!!
Not! all! drugs! used! in! the! treatment! of! TB! were! included! in! this! study.! Drugs! were!
omitted! either! because! insufficient! susceptibility! data! was! available! (e.g.! CIP! and!
rifabutin! (RFB)),! or! because! the! mechanism! of! action! remains! elusive! and! SNPs! to!
predict! resistance! have! yet! to! be! identified! (e.g.! cycloserine! (CYS)! and! para0
aminosalicylic!acid!(PAS)).!
Recent! work! has! shown! that! pyrosequencing! has! sufficient! sensitivity! to! test! DR!
susceptibility! in! Mtb# clinical! specimens,! thereby! significantly! shortening! the!
turnaround!time!for!obtaining!molecular!DST!results!to!hours!(Lin!et#al.!2013).!These!
assays! focus!on!detecting!only! the!most!prevalent!mutations!within!short! sequences!
(<50! bases)! in! limited! numbers! of! genes.! In! contrast,! WGS! technologies! allows!
interrogation! over! all! genes! with! sequencing! of! much! longer! segments,! making! it!
possible!to!identify!mutations!spread!across!the!locus!as!is!the!case!in!pncA!gene.!Low!
frequency!mutations,! which!may! be! predominant! in! certain! geographical! areas! and!
complex!mechanisms!of!resistance!involving!multiple!loci!(e.g.!EMB)!are!also!accessible!
using! WGS.! Potentially! new! DR0conferring! mutations! in! candidate! loci! can! also! be!
investigated!as!demonstrated! in! Section!4.3.4.! Furthermore,!newly! identified!DR! loci!
and!mutations!can!easily!be! incorporated! in! the!mutation! library.!Such! flexibility!will!
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allow! new! drugs! to! be! included,! for! example! bedaquiline,! which! has! recently! been!
found! to! have! cross! resistance! with! clofazimine! through! the! mutations! in! the!
transcriptional!regulator!Rv0687!(Hartkoorn!et#al.!2014).!
Rapid!WGS!may!not!only!replace!current!methods!for!identifying!and!typing!MTBC,!but!
also! has! also! the! potential! to! detect! DR! TB! (Sharon! J.! Peacock! 2013).! Phenotypic!
susceptibility! testing! cannot! still! be! replaced! for! all! antibiotics! since! the! genetic!
mechanisms!of!resistance!are!not!fully!characterised.!Future!work!is!needed!to!identify!
new!loci!closely!associated!with!resistance!to!drugs!like!PZA,!STR,!ETH,!EMB,!MOX!and!
CAP,! and! recently! licensed! anti0TB! drugs.! Nevertheless,!WGS! can! be! used! to! rapidly!
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A! complete! characterisation! of! the! genetic! determinants! of! DR! is! a! prerequisite! for!
accurate!genetic9based!DSTs.!As!well!as!being!a!potential!DR!detection!tool!as!shown!
in!the!previous!chapter,!WGS!can!be!used!to!characterise!new!genes!involved!in!DR.!In!







mutations! found! to! be! associated!with! DR! can! be! incorporated! into! genotypic! drug!
susceptibility! assays! and! facilitate! tailored! treatment! (Lacoma! et# al.! 2008).! On! the!
other! hand,! the! genes! harbouring! these! mutations! can! provide! insights! into! the!
bacterial! mechanisms! that! underlie! DR! and! assist! in! the! rational! design! of! novel!
antimicrobial!agents!(Lee!et#al.!2014).!
Early! attempts! aimed! at! identifying! DR! mechanisms! in! Mtb! consisted! in! studying!
intrinsic! drug! susceptibility! in! other! mycobacterial! species! (Mdluli! et# al.! 1998;!
Danilchanka!et#al.!2008).!High9throughput!mutagenesis!approaches!have!been!used!to!
discover! mutated! loci! responsible! for! changes! in! drug! tolerance,! followed! by!
complementation! with! intact! versions! of! these! loci! that! restored! the! initial! DR!
! 123! !
phenotype! (Danilchanka! et# al.! 2008;! Ren! &! Liu! 2006).! In# vitro! drug! exposure! and!
subsequent! isolation! of! surviving! resistant! mutants,! a! process! known! as! directed!
evolution,! has! also! been! used! to! identify! the! genetic! changes! responsible! for! DR!
acquisition!(Hartkoorn!et#al.!2014;!Safi!et#al.!2013).!These!studies!have!characterised!
multiple!DR!acquisition!pathways,! including!the!role!of!cell9wall!permeability!and!the!
involvement! of! efflux! pumps.! Once! DR! genes! are! identified,! allelic! exchange!
experiments!have!been!extremely!useful!at!establishing!causality!and!elucidating!the!




drug!phenotype! characterisation,! can!be! a! powerful! approach! to! dissect! the! genetic!
determinants!of!DR!and!other!clinically!important!phenotypes.!






resistance! (S.! Zhang! et# al.! 2013).! Genome9wide! association! analysis! (GWAS)! is! a!
powerful! approach! established! in! human! disease! (Anon! 2007),! with! established!
statistical!techniques,!which!aims!to!measure!the!statistical!significance!of!phenotype9











In! parallel,! a! novel! method! to! identify! genetic! markers! of! resistance! was! recently!
developed! (Farhat! et# al.! 2013)! and! applied! to! MTBC! clinical! strains! with! different!
antibiograms.!This!method!consists!of!sequencing!the!genomes!of!related!strains!with!
different!resistance!phenotypes!followed!by!a!phylogenetic9based!genome9wide!scan!
for!positive! selection.! This! approach! (phyC)! assumes! that! genetic! variants!associated!
with! DR! are! under! convergent! positive! selection! and! therefore! originate! de# novo!
across! independent! lineages! (i.e.! branches! of! the! phylogenetic! tree).! This! test! has!
shown!to!be!valuable!as!it!identified!well!known!DR!markers!in!MTBC.!The!involvement!
of!drug!efflux!pumps!and!DNA!repair!genes!in!DR!acquisition!was!also!highlighted.!
In! addition! to! association! studies,! WGS! can! also! shed! light! on! the! molecular!
mechanisms! underlying! the! transmissibility! and! persistence! of! DR! strains! in! a!
population.!It!is!well!known!that!DR!acquired!mutations!may!infer!a!fitness!cost!in!the!
absence!of!antibiotic!pressure!(de!Vos!et#al.!2013).!Compensatory!mutations!may!then!
arise! and! restore! the! fitness! of! resistant! bacteria.! This! insight! has! important!
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epidemiological! consequences! as! MTBC! DR! clinical! strains! harbouring! fitness9
compensatory! mutations! have! been! associated! with! higher! transmissibility! and!
persistence!in!the!population!(de!Vos!et#al.!2013;!Casali!et#al.!2014).!
A! collection! of! 2765! MTBC! isolates! from! 18! global! populations! and! different!
antibiograms!(27.7%!MDR,!17.1%!XDR)!has!been!used!to!identify!novel!mechanisms!of!
DR.! Two! complementary! approaches! were! applied! to! this! dataset:! tree9based!
convergent!evolution!(Farhat!et#al.!2013)!and!GWAS.!Previously!known!resistance!loci!
were! identified! by! the# phyC! analysis! as! well! as! PE/PPE! genes! and! other! potential!
targets!of!convergent!positive!selection.!The!GWAS!analysis!identified!all!known!drug9








publicly! available.! For! the! remaining!ones,! both! the!phenotypic! and!WGS!data!were!
provided!by!collaborators!(see!WGS!data!set!3!description!in!Section!1.7).!!
The! percentage! of! DR! varied! across! populations! and! was! particularly! low! in! the!




















Brazil! 108! 106! 110! 7606! 4!(100)! 100! 100! 10.38!
Bulgaria**! 17! 17! 155! 6329!
2!(5.88),!3!(5.88),!4!
(82.35),!M.#bovis!(5.88)! ND! ND! ND!
China!(H.!
Zhang!et#al.!
2013)*! 161! 130! 106! 16537!
2!(70.77),!3!(1.54),!4!
(26.92)! 73.08! 73.08! 4.62!
Colombia! 15! 15! 111! 2764! 4!(100)! 100! 100! 0!
Vancouver!
(Gardy!et#al.!
2011)*! 36! 33! 55! 1035! 4!(100)! 0! 0! 0!
India! 17! 15! 59! 5878!
1!(26.67),!2!(6.67),!3!(40),!
4!(26.67)! 13.33! 13.33! 0!
Japan**! 4! 4! 283! 1603! 4!(100)! ND! ND! ND!
Karachi! 42! 42! 485! 7681!
1!(11.90),!3!(78.57),!4!
(9.52)! 88.1! 88.1! 0!
Karonga!
(Malawi)! 1662! 1642! 99! 43064!
1!(16.50),!2!(4.08),!3!
(11.69),!4!(67.42),!mixed!
(0.18)! 7.31! 0.61! 0!
Lisbon!
(Perdigão!et#
al.!2013)! 84! 70! 206! 6518!
2!(7.14),!3!(1.43),!4!
(91.43)! 72.86! 54.29! 1.43!
Netherlands**! 14! 14! 389! 992! 4!(100)! ND! ND! ND!
Peru! 104! 99! 290! 8700! 2!(6.06),!4!(93.94)! 61.62! 27.27! 0!




2012)*! 42! 23! 36! 2524! 2!(100)! 65.22! 52.17! 8.7!
South!Africa! 174! 172! 188! 15478!
1!(0.58),!2!(31.98),!3!
(5.81),!4!(61.63)! 98.26! 48.84! 1.16!
Kampala,!
Uganda**! 51! 51! 256! 8019!
1!(1.96),!2!(1.96),!3!
(27.45),!4!(68.63)! ND! ND! ND!
Vietnam! 50! 47! 192! 9256!
1!(36.17),!2!(44.68),!4!
(19.15)! 53.19! 40.43! 0!
WHO9TDR**! 190! 157! 123! 21689!
1!(9.55),!2!(23.57),!3!
(3.18),!4!(63.69)! ND! ND! ND!
Overall! 2902! 2765! 136! 107462!
1!(10.7),!2!(11.6),!3!(9.4),!
4!(66.6),!M.#bovis!(0.04)!
and!mixed!(1.7)! 27.70! 17.09! 1.03!
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(i.e.! resistant! to! both! INH! and! RMP),! and! 1%! were! XDR9TB! (MDR! in! addition! to!
resistance!to!any!FLQ!and!AMI).!It!should!be!noted!that!each!sample!was!tested!for!a!
different!number!of!drugs,!where!susceptibility! to! first9line! treatments!usually! led! to!
no!tests!for!second9line!drugs.!
The! sequence!data! analysis! procedures! used! are! explained! in! Section! 2.2.1.! In! brief,!
after! mapping! the! raw! sequence! data! to! the! H37Rv! reference! genome,! SNPs! were!
called! and! retained! if! present! in! unique! regions! of! the! genome! resulting! in! 107,462!
SNP! sites.! Samples! were! removed! if! they! had! more! than! 15%! of! SNP! missing! calls!
(n=2,765/2,902).!
5.2.2 Phylogenetic!reconstruction!and!population!structure!
The! best9scoring!maximum! likelihood! phylogenetic! tree!was! computed! using!RAxML!
(Stamatakis!et#al.!2008)!based!on!the!107,462!SNP!sites!spanning!the!whole!genome!
and! the! resulting! tree! rooted! on!M.# canettii! as! described! before! (Section! 3.2.4).! All!
isolates! were! in# silico! genotyped! using! SpolPred! (Section! 3.2.2).! The! proposed! SNP!
typing! system! described! in! Section! 3.3.3! was! employed! to! accurately! genotype! all!























Since! resistance! to! anti9TB! drugs! originates! on! top! of! pre9existing!DR,! as! a! result! of!









refer! to! log! odds! of! intercept! and! the! corresponding! variables! respectively.! For!
example,! the! model! for! estimating! the! association! of! resistance! to! PZA! of! Rv2043c!
(pncA)!used!the!number!of!nsSNPs!for!each!sample!within!Rv2043c#(SNP),# INH,!RMP,!
STR,! and! EMB! as! binary! variables! indicating! the! results! of! these! tests! for! samples!
(Previous).!Statistical!significance!of!each!variable!was!established!using!a!Wald!test.!





Genome! analysis! performed! on! 2,765! MTBC! clinical! isolates! from! 18! independent!
populations! revealed! substantial! genetic! diversity,! with! 107,462! SNP! sites! in! non9
repetitive! regions! of! the! genome! relative! to! the! H37Rv! reference! strain.! Figure! 5.1!
shows! the! phylogenetic! tree! constructed! using! all! 107k! SNPs.! In! addition,! samples!
were!classified!using!the!62!strain9specific!SNP!system!(Section!3.3.3)!and!colour9coded!




































excluding! potential!mixed! samples! (n=46,! 1.7%),! representatives! of! lineage1! (n=296,!
10.7%)!and!all!main!three!modern!MTBC!lineages!(2,!n=322,!11.6%;!3,!n=259,!9.4%;!4,!
n=1842,!66.6%)!were!reported.!
In! order! to! highlight! possible! cases! of! DR! transmission,! samples! in! the! phylogenetic!
tree!were!colour9coded!by!DR!status!(Figure!5.2A),!namely!as!pan9susceptible!(sample!
susceptible! to! all! drugs! for! which! it! was! tested),! INH!mono9resistance,! RMP!mono9
resistance,!MDR!and!XDR.!Overall,!27.7%!of!samples!were!at!least!resistant!to!one!anti9
TB! drug,! 17.1%! were! MDR! and! 1%! XDR.! Figure! 5.2C! shows! a! plausible! scenario! of!
ongoing!DR!transmission!among!samples!from!Lisbon!(Perdigão!et#al.!2013)!and!Porto!
populations,!whereas!Figure!5.2B!illustrates!the!development!of!DR!in!multiple!strains!
independently! and! an! apparent! absence! of! DR! transmission! in! samples! from! the!
Karonga,!Malawi,!population.!
5.3.2 Phenotypic!drug!resistance!explained!by!known!candidate!genes!
It! was! first! determined! whether! phenotypic! resistance! could! be! explained! by!
mutations! in! previously! described! DR9associated! genes.! The! compiled! library! of!
putative!DR!mutations!(Section!4.2.1)!was!used!to!infer!an!in#silico!DR!phenotype!from!
the! genomic! data.! These! “inferred”! phenotypes!were! then! compared! to! those! from!







the!exception!of!OFX! (83.3%)!and!KAN! (82.7%).!Having! found! that! some!drugs!were!
not!explained!well!by!the!mutation!library,!the!focus!shifted!to!drug9resistant!samples!







as! the! proportion! of! resistant! and! susceptible! cases! among! tested! samples! (enclosed! in! square!
brackets).!
For! each! drug,! Table! 5.2! includes! the! number! of! DR! samples! lacking! known! DR!
mutations! (column! 2),! and! the! subset! of! these! (column! 5)! harbouring!mutations! in!
candidate!genes!that!could!potentially!be!the!cause!of!resistance!(column!3).!
For!example,!of!the!100!INHR!isolates!without!known!resistance!markers,!10!harboured!
mutations! in! katG! (4! indels! and! 9! nsSNPs)! that! can! potentially! explain! the! resistant!
phenotype.! Strain! specific! mutations,! sSNPs! and! mutations! present! in! susceptible!
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samples!were!not!regarded!as!potentially!DR9conferring!mutations.!Still,!46!potentially!
novel! ones! (35! nsSNPs! +! 11! indels)! could! be! added! to! the! library! of! DR! mutations!


















































OFX! 30! R448H_gyrA,!R592S_gyrA! G668D_gyrA,!E21Q_gyrA,!S95T_gyrA! 2!
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As! the! population! structure! may! confound! the! outcome! of! a! GWAS,! a! PCA! was!
conducted.!The!first!three!principal!components!(PCs)!captured!73.2!%!of!the!variance!
and!as!expected!they!distinguished!the!four!main!lineages!(1!to!4)!unambiguously.!PCs!
4! and! 5! provided! further! sub9division! at! the! sub9lineage! level,! particularly! within!
lineage!4.!These!five!PCs!captured!82.1!%!of!the!variance!all!together!and!were!used!
directly!as!covariates!in!the!logistic!regression!models!(Figure!5.4).!!
Another! expected! confounder! is! the! background! DR,! namely! the! existence! of!
resistance!to!other!drugs!other!than!the!one!being!tested!for!association.!Figure!5.5A!
and! Figure! 5.5C! show! the! GWAS! results! for! INH! before! and! after! adjusting! for!
overlapping! resistance! respectively.! Figure! 5.5B! shows! the! number! of! INHR! samples!
being!also!resistant!to!other!drugs.!Well9known!DR!loci!(katG,! inhA,!fabG1!promoter,!
rpoB,!embB,!pncA! and! rpsL)!were! found! to! be! strongly! associated!with! INHR! (Figure!
5.5A).!The!strength!of!association!of!genes!not! involved!in! INHR!dropped!significantly!





additionally! performed! at! the! operon! level.! As! genes! in! the! same! operon! are! co9
transcribed! and! generally! participate! in! the! same! function,! certain! DR! acquisition!
pathways! may! involve! mutations! in! multiple! genes! (including! the! promoter)! of! the!






(A)! INH!GWAS!performed! for! both! coding! and! intergenic! regions.! The! y9axis! is! the! log10!p9value.! For!
example,! a! value! of! 2! refers! to! a! p9value! of! 0.01.! Loci! are! colour9coded! by! functional! category! and!












































The! majority! of! well9known! DR! loci! were! identified! (Figure! 5.595.14)! which!





associated! gene),! rpoC! (RMPR9associated)! and! gyrB! (FLQR9associated).! In! addition! to!
the!classical!DR!genes!encoding!for!drug9targets!and!drug9converting!enzymes,!a!group!
of! highly! and! intermediately! DR9associated! loci! were! also! identified.! Characterised!
transporters!(e.g.!dppC,!Rv1668c,!mmpL3,!ugcC!and!Rv0194),!probable!transmembrane!
proteins!(e.g.!Rv3061,!Rv3069,!Rv0143c,!Rv0037c,!Rv2799!and!Rv0235c),!PE/PPE!genes!
(e.g.! PE34,! PPE55,! PPE57,! PE_PGRS28,! PE_PGRS7,! PE_PGRS43! and! PE_PGRS18)! and!





they! may! underlie! more! complex! mechanisms! of! DR.! Indeed,! these! transcriptional!
regulators! were! found! to! be! intermediately! associated! with! resistance! to! multiple!
drugs!(Supplementary!Table!10)!with!the!exception!Rv1816,!being!strongly!associated!
with!ETHR!(Figure!5.11).!




and! inhA)! was! closely! related! to! INH! and! ETH! resistance! as! expected,!Rv1907cSfurA!
(containing! katG#and! katG#promoter)! to! INH,!embASembB! to! EMB,!Rv2037cSpncA! to!
PZA! and! rpsLSrpsG! to! STR.! In! addition! to! these! expected! hits,! the! operon! GWAS!
revealed! potentially! new! players! involved! in! DR! including! the! ugpCSugpA! operon,!
which!encodes!for!an!ABC!transporter;!Rv1635c,!possibly!involved!in!the!biosynthesis!
of! lipoarabinomannan;! pstBSpstS1,! an! ABC9type! lipoprotein! transporter;! and! other!
functionally! uncharacterised! operons! (Rv2295,! Rv2203,! Rv3528c,! ccrBSRv3071,!
Rv2313cSRv2315,! Rv3067).! These! results! demonstrate! the! usefulness! of! an! operon9
based!GWAS!approach!to!discover!functionally9related!regions!associated!with!DR.!
PhyC%results!
If! hits! established! using! association! methods! are! also! under! selective! “convergent!
evolution”!pressure,!then!this!provides!strong!evidence!of!their!role!in!resistance.!The!
phylogenetic! converge! test! indentified! the! vast! majority! of! known! resistance!
determinants! (Figure! 5.15,! in! red;! Supplementary! Table! 10,! grey! background! rows);!
recently! described!DR9associated! genes:! folC! (Zhao! et# al.! 2014)! and!ubiA# (Safi! et# al.!
2013);!and!other!targets!of!independent!mutation!(TIM)!in!both!coding!and!intergenic!
regions.!A!sizeable!number!of!TIMs!mapped!to!the!large!family!of!PE/PPE!genes!(Figure!
5.15,! in!blue).!A! few!cases!of! genes! involved! in! cell!wall! biosynthesis!or! remodelling!
were! found! (lppB,! lprP,! mmpL12,! pks7,! pks12! and! pks15).! Despite! the! proven!
usefulness! of! the! phyC# test! for! uncovering! genetic! determinants! of! DR,! there! are!
several! inherent! limitations! to! this#approach! (Farhat!et#al.!2013).!First,! the!detection!
power! drops! significantly! for! drugs! with! high! proportion! of! missing! (i.e.! non9
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determined)!cases.!This!may!result!in!statistically!non9significant!results!for!second9line!
drugs.! Secondly,! the! background! resistance! confounding! effects! cannot! be! adjusted,!
meaning! that! drug9specific! mutations! are! challenging! to! dissect! in! the! presence! of!






regions.! Coding! and! intergenic! regions! are! placed! along! the! Mtb! chromosome! in! this! Circos!





Improving! our! understanding! of! the! relationship! between! the! genotype! and! the! DR!
phenotype!in!Mtb!will!aid!in!the!development!of!more!accurate!molecular!diagnostics!
for! drug9resistant! TB.! Such! insights! may! be! used! to! overcome! or! complement! the!
limitations! of! phenotypic! susceptibility! testing.! The! identified! associations! can! shed!
light! on! the!molecular!mechanisms! underlying! DR! and! assist! in! the! design! of! novel!
antibiotics!(Lee!et#al.!2014).!!
WGS!offers!the!opportunity!to!capture!the!genomic!diversity!of!Mtb#clinical!specimens!
which,! coupled!with! an! accurate! phenotype! characterisation,! can!be!used! to! dissect!
the!genetic!determinants!of!DR.!In!this!context,!it!may!be!challenging!to!pin!down!new!
DR! loci! because! of! the! diverse! genetic! background!of! clinical! strains! (S.! Zhang!et# al.!
2013).#To!overcome!this!limitation,!a!large!collection!of!whole9genome!sequenced!Mtb!
clinical! isolates! (n=2,765)! was! employed! in! this! work,! covering! the! four! major!Mtb!
lineages! and! progressively! resistant! isolates! from! independent! studies.! It! was! also!
ensured!that!the!final!dataset!had!a!sizable!representation!of!pan9susceptible!samples!
with!diverse!genetic!backgrounds.!
First,! the! proportion! of! samples! with! mutations! in! known! DR! candidate! genes! that!
could! explain! the! observed! phenotypic! resistance! was! calculated.! This! preliminary!






Rather! than! testing! each! mutation! independently! for! association,! genomic! variants!
(SNPs)! were! aggregated! by! gene! and! intergenic! region! (only! nsSNPs! in! the! case! of!
protein!coding!regions).!As!a!complementary!approach,!SNPs!were!also!aggregated!by!




addition! to! classical! DR! genes,! other! classes! of! genes! and! operons! likely! to! confer,!
contribute! to! or! compensate! for! phenotypic! resistance! were! also! identified.! The!
discovery! of! membrane! transporters! and! efflux! pumps! is! not! accidental,! as! their!
activity!is!expected!to!affect!drug!transport!and!therefore!drug!susceptibility!(Black!et#
al.! 2014;! Balganesh! et# al.! 2012;! Machado! et# al.! 2012;! Danilchanka! et# al.! 2008).!
Although! comprehensively! studied! in# vitro,! the! precise! role! of! these! transporters! in!
clinically!resistant!isolates!is!controversial!(Black!et#al.!2014).!The!strong!association!of!
Rv0194#with! ETHR! provides! evidence! of! a!multidrug! efflux! pump! (Danilchanka! et# al.!
2008)!potentially!conferring!DR!in!clinical!isolates.!The!use!of!inhibitors!of!efflux!pumps!
has! been! advocated! for! preventing! the! emergence! of! MDR9TB! during! treatment!
(Machado!et#al.!2012).!
An! intrinsic!resistance!mechanism!to!antibiotics!results! from!reduced!permeability!of!
the! bacterial! cell! wall.! Genes! belonging! to! ‘lipid!metabolism’! and! ‘cell! wall! and! cell!
processes’!categories!are!particularly!enriched!among!GWAS!and!phyC!hits,! including!
the! PE/PPE! genes! (which! encode! for! a! group! of! secreted! proteins),! lipoproteins,!
integral!membrane!proteins!and!membrane!proteins!involved!in!lipid!transport!(mmpL!
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genes).! These! hits! are! of! notable! interest! given! their! potential! influence! in! cell! wall!
permeability! and! fluidity,! which! in! turn! determines! drug! susceptibility! (Mdluli! et# al.!
1998;!Danilchanka!et#al.!2008).!On!the!other!hand,!it!cannot!be!discounted!that!these!
genes! are! involved! in! compensatory!mechanisms! trying! to! ameliorate! the! effects! of!
anti9TB!drugs!on!cell!wall!integrity,!as!some!of!the!cell!wall!biosynthetic!pathways!are!
indeed!targeted!by!current!TB!drugs!(e.g.!INH,!ETH!or!EMB).!!
The! unexpected! observation! of! putative! transcriptional! regulatory! proteins! (Rv1816,!
Rv3736,! Rv0275c! and! Rv2736c)! associated! with! DR! is! an! intriguing! finding.! These!
transcriptional!regulators!are!found!to!be!intermediately!associated!with!resistance!to!
multiple! drugs! with! the! exception! of! Rv1816,! being! strongly! associated! with! ETHR.!




of! INHR! isolates! without! known! INHR9conferring! mutations! (n=90)! belong! to! South!
Africa! (n=56),! which! may! reflect! problems! in! DST! determination! for! this! particular!
population.!Still,!the!finding!of!well9known!DR!loci!demonstrates!the!robustness!of!the!
analysis!to!overcome!these!limitations.!
A! challenge! in! DR! loci! discovery!when! using!Mtb! clinical! isolates! is! the! confounding!
effect! of! background! resistance.! Development! of! resistance! in!Mtb! occurs! with! the!
stepwise! use! of! drugs,! in! response! to! increasingly! resistant! TB.! Unlike! the! phyC!
approach,! logistic! regression!adjusted!for!overlapping!resistance!managed!to!remove!
most!of! the!associations!that!were! likely!due!to!confounding!resistance.! It!should!be!
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noted!though,!that!a!drawback!of!adjusting!for!co9occurring!resistance!can!be!the!non9
detection!of! shared!DR!mechanisms,!or! removal!of! signals! if! the!overlap! is!high.! For!
instance,! the! association! of! rpoC! with! RMPR! was! lost! after! adjusting! for! INHR!
(Supplementary! Table! 10).! gid! and! ethA! genes! were! intermediately! associated! with!
INH!and!RMP! resistance!before! adjusting! for!overlapping! resistance.! !However,! they!
were!not!found!to!be!significantly!associated!with!STR!and!ETH!respectively!by!neither!
the! GWAS! nor! the! phyC# approaches.! The! fact! that! these! two! genes! are! thought! to!
cause! intermediate! levels! of! resistance! (Morlock! &!Metchock! 2003;! Perdigão! et# al.!
2013)!may!explain!why!there!were!not!detected.!DR!is!frequently!treated!as!a!binary!
variable! (resistance! or! susceptible)! although! a! range! of! MIC! values! are! indeed!
measured! in!clinical! isolates.!Samples!with! intermediate! levels!of!resistance,! i.e.!with!
MIC!values!around!the!cut9off!used!to!determine!resistance,!may!be!equally!classified!
as! resistant! or! susceptible.! Therefore,! the! employed! association! analyses! will! have!
limited! statistical! power! to! detect! loci! involved! in! low! or! intermediate! levels! of!
resistance.!The!use!of!quantitative!values!of!DR,!i.e.!MIC!values,!and!linear!regression!
rather! than! logistic! regression! could! potentially! be! more! powerful! to! assess! DR!
phenotype9genotype!associations.!
Future! work! could! consider! approaches! that! are! complementary! to! GWAS,! such! as!
pathway9based!methods!to!assess!the!combined!contribution!of!multiple!genes!acting!
within! canonical! biological! pathways! (Eleftherohorinou! et# al.! 2009),! and! logistic!




have! major! functional! consequences,! also! in! DR! (Machado! et# al.! 2012),! and! must!
therefore! be! taken! into! account.! Irrespective,! any! genetic! mutations! found! to! be!
associated!with!resistance!to!a!specific!drug!should!then!be!experimentally!validated.!
Functional! genetic! experiments,! like! allelic! exchange,! can! establish! the! casual!






































studies! although! it!may! have! greater! functional! impact! due! to! their! larger! size.! This!
work!describes!the!implementation!of!a!bioinformatic!workflow!to!effectively!extract!
genetic! polymorphisms! from! WGS! data! of! Mtb# clinical! isolates! (Section! 2.2.1).! In!
addition! to! SNPs! and! small! indels,! large! deletions! were! discovered! by! detecting!
multiple! signals! in! alignment! files! (i.e.! DOC,! read9pair! and! split9read)! to! increase!
sensitivity.! Although! large! chromosome! rearrangements! are! rare! in!MTBC! genomes!
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(Shitikov!et#al.!2014),!large!insertions!(i.e.!longer!than!the!read!length)!are!expected!to!




been! developed! to! specifically! detect! them! albeit! specific! for! the! human! genome!
(Hormozdiari! et# al.! 2010).! Novel! insertions! (i.e.! sequences! absent! in! the! reference!
genome)! cannot! be! identified! using! reference9based! mapping! approaches.! Future!
work!should!investigate!the!accuracy!of!a!whole9genome!de#novo!assembly!approach!
for!the!characterisation!of!all! types!of!SVs! in!MTBC!strains! (Li!2012).!Also,!such!work!
should! attempt! to! confirm! all! or! a! subset! of! observed! variation! using! another!
technology,! e.g.! capillary! sequencing.! Although,! this! was! not! possible! in! this! work!
because! all! DNA! was! used! in! sequencing,! the! high! coverage! achieved! and! quality!
control!means!that!the!false!positive!rate!is!expected!to!be!low.!
Some! regions! of! the! genome! were! excluded! from! analysis.! PE! and! PPE! genes! are!
generally!excluded!from!genome!analyses!because!of!their!high!GC!content!and!their!
repetitive!nature!(McEvoy!et#al.!2012;!Adindla!&!Guruprasad!2003;!Mukhopadhyay!&!
Balaji! 2011),!which!make! sequencing!and!genome!assembly!difficult.!GC9rich! regions!
are! under9sampled! by! Illumina! sequencers,! resulting! in! coverage! gaps! and! lower!
confidence!in!these!regions.!In!addition,!mapping!of!reads!from!the!PE!and!PPE!genes!
to! the! reference! genome! is! prone! to! errors! as! the! regions! are! not! unique! and! can!
result!in!artefacts,!e.g.!false!positive!SNP!calls!(Nielsen!et#al.!2011).!A!de#novo!assembly!
approach! would! be! better! at! resolving! these! genes! provided! that! enough! depth! of!
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coverage!is!achieved.!A!recent!study!(Bryant,!Harris,!et#al.!2013)!demonstrated!that!a!
large! proportion! of! PE! and! PPE! genes! (86%)! can! be! assembled! and! their! genetic!
variants!discovered.!Despite!accounting! for!almost!10%!of! the!coding!capacity!of! the!
genome,! the! function!of! PE! and!PPE! genes! remains! elusive! (Mukhopadhyay!&!Balaji!
2011).!!
The!work!describes!data!from!first!(Sanger!capillary)!and!second9generation!(Illumina)!
sequencing! technologies,! but! a! third! generation! of! platforms! is! under! development.!
Technologies!such!as!Oxford!Nanopore!(Branton!et#al.!2008;!Timp!&!Mirsaidov!2010)!
and!Single!Molecule!Real!Time!(SMRT)!PacBio!sequencing!(Liu!et#al.!2012)!promise!to!
deliver! longer! and!more! accurate! reads! at! high! throughput! and! reduced! costs.! The!
average!read!length!achieved!by!PacBio!sequencers!(Pacific!Bioscience,!California,!USA)!
is! 1,300! bp,! longer! than! any! current!NGS!platform! (Glenn! 2011).! As! a! consequence,!
algorithms!and!workflows!for!sequence!analysis!will!have!to!be!adapted!and!evolve!to!
accommodate! these!changes! (Satou!et#al.!2014;!Boetzer!&!Pirovano!2014).! It! can!be!




limitations! of! current! Illumina! sequencers,! 98%! of! the!Mtb#genome! can! be!mapped!
uniquely!using!75!bp9long!reads!(compared!to!83.1%!of!the!human!genome)!(Derrien!




Despite! the! growing! amount! of! genomic! data! being! generated! from! Mtb! clinical!











of!Mtb#WGS! studies.! Knowledge! of! the! genetic! diversity! across! populations,! among!
other!factors,!will!assist!in!the!understanding!of!Mtb!biology,!required!to!develop!new!
drugs! and! novel! vaccines.! Strain9specific! genomic! diversity! in!MTBC# is! an! important!
factor! in! pathogenesis! that! may! affect! virulence! (Nahid! et# al.! 2010;! Thwaites! et# al.!
2008;! Caws! et# al.! 2008),! transmissibility! (Kato9Maeda! &! Kim! 2010),! host! response!
(López!et#al.!2003)!and!emergence!of!DR!(Ford!et#al.!2013).!Several!systems!have!been!




SNPs! lack! resolution! (Stucki!et# al.! 2012)! or! do! not! capture! known! circulating! strain9
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types! (Homolka!et# al.! 2012).! The! SNP! barcode! developed! in! this!work! is! the! first! to!
cover! all! main! lineages,! including! the! recently! discovered! lineage! 7! (Firdessa! et# al.!
2013),!and!classifies!a!greater!number!of!sub9lineages!than!current!alternatives.!It!also!
outperforms!the!other!SNP!systems.!One!of!the!latest!published!SNP!sets!(Homolka!et#
al.! 2012)!was!employed! in! recent! studies! to! type!Mtb# strains! after!undergoing!WGS!
(Casali!et#al.!2014;!Chernyaeva!et#al.!2014).!Still,!36%!of!isolates!could!not!be!classified!
(Casali!et#al.!2014),!particularly! those! from!the!Euro9American! lineage,! for!which! the!
global!diversity!is!not!fully!captured!by!this!scheme.!All!samples!in!that!study!could!be!
unambiguously! classified! using! the! SNP! barcode! in! this! work! (Section! 3.3.4).!




as! multiplex! ligation9dependent! probe! amplification! (MLPA)! assays! (Bergval! et# al.!
2012;! Sengstake! et# al.! 2014),! multiplexed! oligonucleotides! ligation! PCR! (MOL9PCR)!
(Deshpande! et# al.! 2010),! or! TaqMan! real9time! PCR! (Stucki! et# al.! 2012).! Since! these!
methods! differ! in! their! technical! requirements,! different! SNP! sets! may! be! required!
depending!on!the!particular!platform!(Kim!&!Misra!2007).!Still,!given!the!redundancy!





studies! such! as! those! investigating! host9pathogen! interactions! during! TB! infection,!
wherein!strain9type!is!likely!to!be!an!important!factor!in!pathogenesis.!It!is!known!that!
population! structure! can! lead! to! false! positive! associations! when! considering!
phenotypes! like! drug! resistance,! and! knowledge! of! strain9specific! markers! can!
minimise! the! spurious! findings.! In! the! context!of! clinical! trials,! the!barcode!could!be!
applied! to! evaluate! new! TB! vaccines! whose! protective! efficacy! may! vary! by! the!
genotype!of!the!infecting!strain!(López!et#al.!2003).!
Despite! the! limitations! of! current! genotyping! techniques! (i.e.! spoligotyping,! MIRU9
VNTR!and!RFLP)!compared!to!SNP9typing,!they!are!still!broadly!employed!in!reference!
and! research! laboratories.! There! are! available! databases! with! hundreds! of! MTBC!
isolates! typed! using! classical! genotyping! (Demay! et# al.! 2012),! and! their! strain!
nomenclature! widely! employed! in! the! literature! (e.g.! LAM,! Haarlem! or! Beijing).!
SpolPred! has! proved! to! be! a! useful! tool! to! predict! spoligotype! from!WGS! data.! In!
addition! to! being! used! throughout! this! work,! it! has! been! employed! by! others.! For!
example,! in! epidemiological! studies! where! experimental! genotypic! data! may! be!
present!(Guerra9Assunção!et#al.!2014),!thus!a!source!of!confirmation,!or!absent!(Liu!et#
al.! 2014;! Rashdi! &! Jadhav! 2014)! where! a! strain9type! needs! to! be! identified.! Future!
work! may! consider! predicting! MIRU9VNTR! patterns! from! WGS! data.! Their! in# silico!
determination! from! short! sequencing! reads! is! expected! to! be! computationally!
challenging! as! the! current! read! lengths! (509100! bp)! may! not! span! multiple! VNTR!
repeats.!Determination!of!RFLP!patterns!would!rely!on!an!accurate!reconstruction!of!
the!whole! genome,! followed! by! in# silico! ‘digestion’! of! the!WGS!with! the! restriction!
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enzyme!and!estimation!of! the!bands! length.! Irrespective,! in# silico! typing! approaches!
for! Mtb! could! be! tested! and! validated! as! datasets! with! both! the! experimentally!
determined!genotype!and!WGS!are!available!(Pérez9Lago!et#al.!2014;!Bryant,!Harris,!et#
al.! 2013;! Guerra9Assunção! et# al.! 2014).! Similar! approaches,! particularly! aimed! at!
predicting! multi9locus! sequence! types! (MLST)! from! short! reads,! have! also! been!
developed!for!other!bacterial!genomes!(Inouye!et#al.!2012).!
Combining! strain! identification! with! drug! susceptibility! determination! will! further!
enhance! the! usefulness! of! the! barcode.! Genetic! profiles! of! resistance! are! valuable!
clinical! information! to! design! tailored! drug! regimens.! Knowledge! of! the! genetic!
background!of!circulating!strains!can!provide!insights!into!DR!emergence!and!spread.!
In!that!respect,!the!identification!of!similar!strains!in!more!than!one!patient!sharing!DR!
mutations! is! likely! to! reflect! transmission! of! DR! between! them,! and! allow! early!
interventions! to! avoid! onward! transmission.! In! addition,! associations! of! particular!
strain!types!and/or!DR!profiles!with!poor!treatment!outcomes!or!mortality!could!also!
be! determined.! A! rapid! genetic! test! incorporating! strain9specific! and! DR! mutations!




levels! of!microbiological! safety.! Phenotypic! DSTs! are! technically! complex,!which! can!
lead! to! variable! reliability! among! laboratories.! Rapid! molecular! assays! are! now!
available!for!some!key!drugs.!They!examine!a!limited!number!of!loci!and!normally!the!
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most! frequent! DR!mutations! only,! which! may! result! in! low! sensitivity,! especially! in!
certain!geographical!regions!where!the!most!common!DR!mutations!are!less!prevalent.!
This!observation!is!the!case!for!INH!detection!using!MDRTBplus#(Jin!et#al.!2012;!Akpaka!




the! relationships! between! the! genotype! and! DR! phenotype.! This! means! that!
phenotypic! DSTs! are! not! replaceable! for! drugs! without! fully! characterised! genetic!
mechanisms!of! resistance!and! for! recently! licensed!drugs! like!bedaquiline,! for!which!
DR!mutations!in!clinical!samples!have!not!been!established.!Nevertheless,!WGS!can!be!
used! to! rapidly! identify! resistance! when! mutations! known! to! be! associated! with!
resistance!are!detected.!In!this!regard,!the!presented!library!of!DR!mutations!(Section!
4.2.1)! is!the!most!complete!and!updated!database!of! its!kind.!The!DR!markers!in!this!
list! can! be! then! used! to! diagnose! DR9TB! from! WGS! data! as! shown! (4.3.1)! or! be!
incorporated!in!alternative!genotyping!platforms!for!the!same!purpose.!
In! addition! to! its! potential! as! a! diagnostic! tool,! WGS! opens! the! possibility! of!
deciphering!novel!mechanisms!of!antibiotic!resistance.!The!complementary!GWAS!and!
selection!detection!methodology!described!in!this!work!to!assess!genotype9phenotype!
association! identified! well9known! drug! targets! and! drug9converting! enzymes.! It!
appears!that!potential!compensatory!mechanisms!(e.g.!rpoC)!may!be!better!detected!
using! the! phylogenetic9based! selection! metrics.! This! work,! as! well! as! (Farhat! et# al.!
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2013;!H.!Zhang!et#al.!2013;!Safi!et#al.!2013),! identifies!new!resistance9associated! loci!
and! expands! our! understanding! of! the! genetic! diversity! underlying! DR! (Warner! &!
Mizrahi! 2013).! It! further! highlights! that! the! genetic! basis! of! DR! phenotypes! can! be!
more!complex! than!previously!anticipated,!and! the!phenotype!may!develop! through!
the!contribution!of!multiple!loci,!resulting!in!a!range!of!drug!susceptibilities!(Safi!et#al.!
2013).! In! light! of! these! observations,! the! binary! classification! of! Mtb! as! either!
susceptible! or! resistance,! rather! than! consideration! as! a! continuous! spectrum,! is! an!
oversimplification! as! it! does! not! account! for! different! levels! of! resistance!present! in!
clinical!strains,!and!complicates!DR!association!analyses.!Future!work!should!consider!
using! quantitative! values! of! DR,! such! as!MIC! values.! A! linear! regression! rather! than!
logistic! regression!would! be! used! to! assess! DR! associations! between!mutations! and!
loci.! Additional! analysis! could! also! take! association! p9values! and! look! for! biological!
pathways!that!may!be!over9represented.!However,!such!analysis!is!dependent!on!well9
characterised!pathway!information!in!Mtb.!
WGS! offers! the! opportunity! to! capture! the! natural! genetic! variation! in! clinical!




succeed! than! performing! directed! evolution! experiments! to! characterise! in# vitro!
acquired!DR!mutations,!which!may!not!be!ever!observed!in!clinical!samples.!
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The! combination! of! genomics! with! other! ‘omic’! approaches,! such! as! proteomics! or!
metabolomics,! opens! the! door! to! the! study! of!more! complex! phenotypes,! including!
host9pathogen! interactions.! These! interactions! are! likely! to! be! complex,! between!
genes! that! are! not! apparent! from! the! genome! sequence! alone.! Transcriptional!
profiling! of! wild9type! and! mutant! strains! –! initially! performed! using! microarrays!
(Butcher! 2004)! and! more! recently! with! RNA9seq! 9! has! been! extensively! applied! to!
study! the! adaptive! responses! of! Mtb.# In! particular,# adaptations! under! certain!
experimental!conditions,!such!as!antibiotic!stress!(Waddell!&!Butcher!2010),!uptake!by!
macrophages! (Monahan! et# al.! 2001)! or! reduction! of! oxygen! and! other! nutrients!
(Rodríguez!&!Hernández!2014).!RNA9seq!has!facilitated!the!mapping!of!transcriptional!
start!sites!(TSSs)!(Cortes!et#al.!2013)!and!identification!of!non9coding!RNAs!in!the!Mtb!
genome! (Miotto! et# al.! 2012).! A! recent! study! used! ChIP9seq! (Chromatin!
Immunoprecipitation!and!Sequencing)!in!Mtb!to!map!transcription!factor!binding!sites!
across! the! genome! for! the! first! time! (Galagan! et# al.! 2013),! resulting! in! a! far! more!
complex! and! interconnected! regulatory! network! than! previously! anticipated.! ! The!
combination!of!RNA9seq!with!ChIP9seq!(Uplekar!et#al.!2013)!and!proteomics!(Cortes!et#
al.! 2013)! can! shed! light! on! more! complex! mechanisms! of! transcriptional! and! post9
transcription!regulation!of!gene!expression.!Systems!biology!approaches!can!provide!a!
deeper! understanding! of! pathogen9host! interactions,! especially! those! involved! in!
latency,! reactivation!and! immune!response! 9!needed!to!develop!better!TB!drugs!and!
more!effective!vaccines.!!
Rapid,!low9cost!genome!sequencing!is!having!a!big!impact!on!molecular!epidemiology,!
evolution!and!diagnosis!of!bacterial! infections,!enabling! researchers!and!clinicians! to!
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gain!insights!at!the!patient,!community!and!global!levels.!The!potential!application!of!





WGS! in! clinical! settings! as! an! important! tool! for! TB! control.! These! possibilities! have!
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7199,!99!(NC_020089)! 1,013! 72.75! 108! 70.37! 12! 41.67!
CAS/NITR204!(NC_021193)! 4,620! 23.79! 1,963! 4.12! 2! 100!
CCDC5079!(NC_017523)! 2,131! 60.39! 385! 25.97! 11! 54.54!
CCDC5180!(NC_017522)! 1,751! 71.50! 185! 55.67! 13! 46.15!
CDC1551!(NC_002755)! 1,222! 66.77! 207! 36.71! 15! 46.67!
CTRI,!2!(CP002992)! 983! 79.14! 99! 69.70! 14! 42.86!
EAI5/NITR206!(NC_021194)! 2,187! 58.71! 251! 29.08! 11! 72.73!
F11!(NC_009565)! 986! 80.16! 92! 75.00! 8! 37.50!
KZN!1435!(NC_012943)! 1,005! 78.50! 113! 55.75! 7! 42.86!
KZN!4207!(NC_016768)! 994! 79.48! 93! 67.74! 6! 66.67!
KZN!605!(NC_018078)! 1,019! 78.02! 112! 56.25! 6! 50.00!
RGTB327!(CP003233)! 1,145! 56.33! 1,821! 2.58! 7! 0.00!
RGTB423!(NC_017528)! 2,615! 71.59! 2,027! 4.53! 4! 0.00!
Beijing/NITR203!(NC_021054)! 2,338! 56.97! 198! 39.89! 0! 0.00!
Erdman!(AP012340)! 1,159! 70.06! 114! 61.40! 25! 32.00!
UT205!(NC016934)! 808! 79.83! 94! 62.76! 13! 69.23!
Overall!! 12,887! ! 6,749! ! 95! !
Summary! of! genetic! variation! extracted! for! a! set! of! 16!Mtb# complete! genomes! downloaded! from!
Genbank.! Genetic! variation! across! all! 16! genomes! was! derived! with! respect! to! the! H37Rv! reference!
genome!(Genbank!accession!number!NC_000962.3).!The!number!of!SNPs,!indels!and!large!deletions!per!
genome!are!shown!in!columns!2,!4!and!6!respectively.!The!percentage!of!variants!also!observed!in!the!
WGS!public!dataset! (namely!present! in!at! least!one!of! the!1,470! isolates! in! the!WGS!data! set!1!after!




















18! 477777777413771! 126! EAI5! 477777777413771! 126! EAI5!
48! 777746777760771! 1721! X1! 777756777760771! 302! X1!
47! 777756777760771! 302! X1! 777756777760771! 302! X1!
10! 717776777760771! 2356! X1! 717776777760771! 2356! X1!
30! 717776777760771! 2356! X1! 717776777760771! 2356! X1!
38! 777777477760771! 451! T9H37Rv! 777777477760771! 451! T9H37Rv!
25! 777767601560751! !9! O! 777777603560771! 228! T1!
35! 777777607760771! 42! LAM9! 777777607760771! 42! LAM9!
27! 777777606060771! 59! LAM11_ZWE! 777777606060771! 59! LAM11_ZWE!
34! 777777606060771! 59! LAM11_ZWE! 777777606060771! 59! LAM11_ZWE!
42! 777777606060771! 59! LAM11_ZWE! 777777606060771! 59! LAM11_ZWE!
36! 777777606060771! 59! LAM11_ZWE! 777777606060771! 59! LAM11_ZWE!
2! Not!determined! 9! 9! 777737606060760! 9! O!
1! Not!determined! 9! 9! 777737606060760! 9! O!
3! Not!determined! 9! 9! 777737606060760! 9! O!
4! Not!determined! 9! 9! 777737606060760! 9! O!
17! 775777606060731! 1549! LAM11_ZWE! 775777606060731! 1549! LAM11_ZWE!
7! Not!determined! 9! 9! 775777606060731! 1549! LAM11_ZWE!
31! 777777777760771! 53! T1! 777777777760771! 53! T1!
16! 777777777760771! 53! T1! 777777777760771! 53! T1!
39! 777777777760771! 53! T1! 777777777760771! 53! T1!
43! 777777777760771! 53! T1! 777777777760771! 53! T1!
20! 000000007760771! !9!! O! 000000007760771! !9!! O!
51! 000000007760731! 125! LAM3! 000000007760731! 125! LAM3!
5! 000000007760771! !9!! O! 000000007760771! !9! O!
6! 000000007760771! !9! O! 000000007760771! !9! O!
37! 637774777760730! 420! T29Uganda! 637774777760730! 420! T29Uganda!
45! 777777777760731! 52! T2! 777777777760731! 52! T2!
9! Not!determined! 9! 9! 777777775760731! 2867! T2!
11! 777777777760731! 52! T2! 777777777760731! 52! T2!
22! 777777777760731! 52! T2! 777777777760731! 52! T2!
23! 777777777760731! 52! T2! 777777777760731! 52! T2!
44! 777777777760731! 52! T2! 777777777760731! 52! T2!
24! 777777777760731! 52! T2! 777777777760731! 52! T2!
46! 777777403760731! !9! O! 777777403760731! !9! O!
28! 777777403760731! !9!! O! 777777403760731! !9!! O!
41! 000000000003771! 1! BEIJING! 000000000003771! 1! BEIJING!
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40! 703767600001771! !9! O! 703777600001771! 356! CAS1_DELHI!
32! 703777740003771! 26! CAS1_DELHI! 703777740003771! 26! CAS1_DELHI!
29! 703777740003771! 26! CAS1_DELHI! 703777740003771! 26! CAS1_DELHI!
33! 703777740003771! 26! CAS1_DELHI! 703777740003771! 26! CAS1_DELHI!
14! 703777740003771! 26! CAS1_DELHI! 703777740003771! 26! CAS1_DELHI!
12! 703777740003771! 26! CAS1_DELHI! 703777740003771! 26! CAS1_DELHI!
13! 703777740003771! 26! CAS1_DELHI! 703777740003771! 26! CAS1_DELHI!
21! 703377400001771! 21! CAS1_KILI! 703377400001771! 21! CAS1_KILI!
26! 703367400001771! 1675! CAS1_KILI! 703377400001771! 21! CAS1_KILI!
8! 700377740003771! 288! CAS2! 700377740003771! 288! CAS2!
49! 700367700003771! !9! O! 700377740003771! 288! CAS2!
50! 700377740003771! 288! CAS2! 700377740003771! 288! CAS2!
15! 700377740003771! 288! CAS2! 700377740003771! 288! CAS2!
16! Not!determined! 9! 9! 700377740003771! 288! CAS2!
Experimental!spoligotype!results!and!SpolPred!predicted!ones!for!51!Ugandan!MTBC!isolates.! 
Supplementary!Table!3!Lineage!composition!of!the!WGS!data!set!2!populations!




















19! 1,021! 0! 0! 0! 100! 0! 0! 0! 0!
China!(H.!Zhang!
et#al.!2013)!
161! 19,314! 0! 75.8! 1.2! 23.0! 0! 0! 0! 0!
Global!(Comas!
et#al.!2013)!


















259! 18,699! 1.5! 58.7! 1.9! 35.9! 0.4! 0! 0! 1.5!
Uganda!(Clark!
et#al.!2013)!
51! 8,019! 2.0! 2.0! 27.5! 68.6! 0! 0! 0! 0!
UK!(Walker!et#
al.!2013)!




4! 2345! 0! 0! 0! 0! 0! 0! 100! 0!















lineage1! 615938! 1104! G/A! 368! GAG/GAA! E/E! Rv0524! hemL#
lineage1.1! 4404247! 1056! G/A! 352! CTG/CTA! L/L! Rv3915! S#
lineage1.1.1! 3021283! 711! G/A! 237! CGG/CGA! R/R! Rv2707! S##
lineage1.1.1.1! 3216553! 339! G/A! 113! GTC/GTT! V/V! Rv2907c! rimM#
lineage1.1.2! 2622402! 51! G/A! 17! GCC/GCT! A/A! Rv2343c! dnaG#
lineage1.1.3! 1491275! 1038! G/A! 346! CAC/CAT! H/H! Rv1326c! glgB#
lineage1.2.1! 3479545! 375! C/A! 125! GCC/GCA! A/A! Rv3111! moaC1#
lineage1.2.2! 3470377! 303! C/T! 101! CAG/CAA! Q/Q! Rv3101c! ftsX#
lineage2! 497491! 810! G/A! 270! GAC/GAT! D/D! Rv0411c! glnH#
lineage2.1! 1881090! 5787! C/T! 1929! GGC/GGT! G/G! Rv1661! pks7#
lineage2.2! 2505085! 615! G/A! 205! GCC/GCT! A/A! Rv2231c! cobC#
lineage2.2.1! 797736! 804! C/T! 268! CTC/CTT! L/L! Rv0697! S#
lineage2.2.1.1! 4248115! 1602! C/T! 534! GAC/GAT! D/D! Rv3795! embB#
lineage2.2.1.2! 3836274! 618! G/A! 206! TTC/TTT! F/F! Rv3417c! groEL1#
lineage2.2.2! 346693! 1059! G/T! 353! TCG/TCT! S/S! Rv0284! eccC3#
lineage3! 3273107! 894! C/A! 298! GCC/GCA! A/A! Rv2936! drrA#
lineage3.1.1! 1084911! 840! G/A! 280! TAC/TAT! Y/Y! Rv0973c! accA2#
lineage3.1.2! 3722702! 930! G/C! 310! CTC/CTG! L/L! Rv3336c! trpS#
lineage3.1.2.1! 1237818! 375! C/G! 125! CTG/CTC! L/L! Rv1111c! S#
lineage3.1.2.2! 2874344! 2142! G/A! 714! CGC/CGT! R/R! Rv2555c! alaS#
lineage4**! 931123! 171! T/C! 57! TAT/TAC! Y/Y! Rv0835! lpqQ#
lineage4.1! 62657! 2262! G/A! 754! CCG/CCA! P/P! Rv0058! dnaB#
lineage4.1.1! 514245! 1077! C/T! 359! GTG/GTA! V/V! Rv0425c! ctpH#
lineage4.1.1.1! 1850119! 1917! C/T! 639! ACG/ACA! T/T! Rv1640c! lysX#
lineage4.1.1.2! 541048! 444! T/G! 148! TCA/TCC! S/S! Rv0450c! mmpL4#
lineage4.1.1.3! 4229087! 741! C/T! 247! AAC/AAT! N/N! Rv3782! glfT1#
lineage4.1.2! 891756! 514! A/G! 172! TTG/CTG! L/L! Rv0798c! cfp29#
lineage4.1.2.1! 107794! 195! C/T! 65! GCC/GCT! A/A! Rv0098! fcoT#
lineage4.2! 2411730! 393! G/C! 131! TCC/TCG! S/S! Rv2152c! murC#
lineage4.2.1! 783601! 1117! A/C! 373! AGG/CGG! R/R! Rv0684! fusA1#
lineage4.2.2! 1487796! 636! C/A! 212! ATC/ATA! I/I! Rv1324! S#
lineage4.2.2.1! 1455780! 286! T/C! 96! TTG/CTG! L/L! Rv1299! prfA#
lineage4.3! 764995! 1626! C/G! 542! GCC/GCG! A/A! Rv0668! rpoC#
lineage4.3.1! 615614! 780! C/A! 260! GCC/GCA! A/A! Rv0524! hemL#
et#al.!2012)!
Overall% 1,601% 91648! 7.5% 24.4% 11.8% 53.4% 1.1% 0.7% 0.4% 0.7%
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lineage4.3.2! 4316114! 483! G/A! 161! GCC/GCT! A/A! Rv3843c! S#
lineage4.3.2.1! 3388166! 705! C/G! 235! ACG/ACC! T/T! Rv3029c! fixA#
lineage4.3.3! 403364! 2478! G/A! 826! CCC/CCT! P/P! Rv0338c! S#
lineage4.3.4! 3977226! 165! G/A! 55! TTG/TTA! L/L! Rv3538! S##
lineage4.3.4.1! 4398141! 1545! G/A! 515! TCG/TCA! S/S! Rv3910! S##
lineage4.3.4.2! 1132368! 744! C/T! 248! ACC/ACT! T/T! Rv1013! pks16#
lineage4.3.4.2.1! 1502120! 522! C/A! 174! ACC/ACA! T/T! Rv1333! S##
lineage4.4! 4307886! 1029! G/A! 343! CGC/CGT! R/R! Rv3834c! serS#
lineage4.4.1! 4151558! 660! G/A! 220! GGC/GGT! G/G! Rv3708c! asd#
lineage4.4.1.1! 355181! 684! G/A! 228! AAG/AAA! K/K! Rv0291! mycP3#
lineage4.4.1.2! 2694560! 405! G/C! 135! CTC/CTG! L/L! Rv2397c! cysA1#
lineage4.4.2! 4246508! 3276! G/A! 1092! GCG/GCA! A/A! Rv3794! embA#
lineage4.5! 1719757! 1032! G/T! 344! CCG/CCT! P/P! Rv1524! S#
lineage4.6! 3466426! 666! G/A! 222! GTC/GTT! V/V! Rv3097c! lipY#
lineage4.6.1! 4260268! 879! G/C! 293! GCC/GCG! A/A! Rv3800c! pks13#
lineage4.6.1.1! 874787! 555! G/A! 185! CCG/CCA! P/P! Rv0781! ptrBa#
lineage4.6.1.2! 1501468! 543! G/C! 181! CCG/CCC! P/P! Rv1332! S##
lineage4.6.2! 4125058! 642! G/C! 214! CGG/CGC! R/R! Rv3683! S##
lineage4.6.2.1! 3570528! 684! C/G! 228! CGG/CGC! R/R! Rv3198c! uvrD2#
lineage4.6.2.2! 2875883! 603! C/T! 201! CTG/CTA! L/L! Rv2555c! alaS#
lineage4.7! 4249732! 3219! C/G! 1073! GCC/GCG! A/A! Rv3795! embB#
lineage4.8! 3836739! 153! G/A! 51! GAC/GAT! D/D! Rv3417c! groEL1#
lineage4.9**! 1759252! 1572! G/T! 524! TCG/TCT! S/S! Rv1552! frdA#
lineage5! 1799921! 339! C/A! 113! GGC/GGA! G/G! Rv1599! hisD#
lineage6! 1816587! 399! C/G! 133! GTC/GTG! V/V! Rv1617! pykA#
lineage7! 1137518! 543! G/A! 181! AAC/AAT! N/N! Rv1018c! glmU#
lineageBOV! 2831482! 1110! A/G! 370! GGT/GGC! G/G! Rv2515c! S##
lineageBOV_AFRI! 1882180! 477! C/T! 159! GCC/GCT! A/A! Rv1662! pks8#
 
Minimum!set!of!62!SNPs!for!MTBC!typing.!SNPs!are!annotated!using!their!chromosome!coordinate!on!










































M.#tuberculosis# BT1! CP002883.1! 2,!!2.2,!!2.2.1! Beijing/W!
M.#tuberculosis# BT2! CP002882.1! 2,!!2.2,!!2.2.1! Beijing/W!
M.#tuberculosis# CAS!NITR204! NC_021193.1! 3! CAS!strain!(Narayanan!&!
Deshpande!2013)!
M.#tuberculosis# CCDC5079! NC_017523.1! 2,!!2.2,!!2.2.1! Beijing!family!(Y.!Zhang!
et#al.!2011)!
M.#tuberculosis# CCDC5180! NC_017522.1! 2,!!2.2,!!2.2.1! Beijing!family!(Y.!Zhang!
et#al.!2011)!





M.#tuberculosis# CTRI92! CP002992.1! 4,!4.3,!!4.3.3! Euro,!American!lineage!4!
strain,!LAM!family,!LAM9!
(Ilina!et#al.!2013)!
M.#tuberculosis# EAI5! CP006578.1! 1,!!1.1! East!African!Indian!
lineage!1,!EAI5!(Rashdi!&!
Jadhav!2014)!!









M.#tuberculosis# HKBS1! CP002871.1! 2,!!2.2,!!2.2.1! Beijing/W!Lineage!!
M.#tuberculosis# KZN1435! NC_012943.1! 4,!4.3,!!4.3.3! Euro,!American!lineage!4!
strain,!LAM!family!
(Feuerriegel!et#al.!2010)!











M.#tuberculosis# KZN605! NC_018078.1! 4,!4.3,!!4.3.3! Euro,!American!lineage!4!
strain,!LAM!family!
(Feuerriegel!et#al.!2010)!
M.#tuberculosis# RGTB327! CP003233.1! 4,!4.3,!!4.3.4! Not!reported!
(Madhavilatha!et#al.!
2012)!







































INH! katG# 4! 2154724*! 1388! C/A! 463! CGG/CTG! R/L! Rv1908c!
INH! katG# BOVAFRI! 2155503! 609! G/A! 203! ACC/ACT! T/T! Rv1908c!
INH! inhA# 6! 1674434! 233! T/C! 78! GTG/GCG! V/A! Rv1484!
INH! ahpC#
promoter#
3! 2726105*! 9! G/A! 9! 9! 9! 9!
INH! kasA# 4.3.3! 2518919! 805! G/A! 269! GGT/AGT! G/S! Rv2245!
INH! ndh# 4.4.1! 2102990! 53! A/G! 18! GTG/GCG! V/A! Rv1854c!
INH! ndh# 5! 2101921! 1122! C/T! 374! TCG/TCA! S/S! Rv1854c!
INH! ndh# 7! 2102218! 825! G/A! 275! GTC/GTT! V/V! Rv1854c!
EMB! embA# 1! 4245969! 2737! C/T! 913! CCG/TCG! P/S! Rv3794!
EMB! embA# 1.1! 4243848! 616! G/A! 206! GTG/ATG! V/M! Rv3794!
EMB! embA# 1.2.1! 4244420! 1188! G/C! 396! GTG/GTC! V/V! Rv3794!
EMB! embA# 2.1! 4246088! 2856! A/G! 952! CAA/CAG! Q/Q! Rv3794!
EMB! embA# 2.2! 4243460*! 228! C/T! 76! TGC/TGT! C/C! Rv3794!
EMB! embA# 4.4.2! 4246508! 3276! G/A! 1092! GCG/GCA! A/A! Rv3794!
EMB! embA# 4.6.1.2! 4245055! 1823! C/A! 608! ACC/AAC! T/N! Rv3794!
EMB! embB# 2.2.1.1! 4248115! 1602! C/T! 534! GAC/GAT! D/D! Rv3795!
EMB! embB# 4.1.1.2! 4246930! 417! G/C! 139! CAG/CAC! Q/H! Rv3795!
EMB! embB# 4.4.1.2! 4249012! 2499! G/A! 833! CTG/CTA! L/L! Rv3795!
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EMB! embB# 4.7! 4249732! 3219! C/G! 1073! GCC/GCG! A/A! Rv3795!
EMB! embB# 7! 4248073! 1560! C/T! 520! ACC/ACT! T/T! Rv3795!
EMB! embB# BOVAFRI! 4246864! 351! C/T! 117! GTC/GTT! V/V! Rv3795!
EMB! embC# 1! 4241042! 1180! A/G! 394! AAC/GAC! N/D! Rv3793!
EMB! embC# 3! 4242075*! 2213! G/A! 738! CGG/CAG! R/Q! Rv3793!
EMB! embC# 3.1.1! 4241562! 1700! G/A! 567! CGC/CAC! R/H! Rv3793!
EMB! embC# 4.1! 4242803*! 2941! G/C! 981! GTG/CTG! V/L! Rv3793!
EMB! embC# 4.1.1.1! 4240897! 1035! C/G! 345! CGC/CGG! R/R! Rv3793!
EMB! embC# 4.6.2.1! 4242883! 3021! C/T! 1007! CCC/CCT! P/P! Rv3793!
EMB! embC# 4.9! 4242643! 2781! C/T! 927! CGC/CGT! R/R! Rv3793!
EMB! embC# 7! 4240153! 291! G/A! 97! TCG/TCA! S/S! Rv3793!
EMB! embR# 1! 1417019! 329! C/T! 110! TGC/TAC! C/Y! Rv1267c!
EMB! embR# 4.6.1.2! 1416410! 938! A/C! 313! CTG/CGG! L/R! Rv1267c!
EMB! embR# 4.6.2.1! 1416702! 646! A/G! 216! TAC/CAC! Y/H! Rv1267c!
EMB! embR# 7! 1416977! 371! T/C! 124! CAC/CGC! H/R! Rv1267c!
EMB! ubiA# 4.4.2! 4268928! 906! G/A! 302! GGC/GGT! G/G! Rv3806c!
EMB! ubiA# 4.4.2! 4269375! 459! C/T! 153! GTG/GTA! V/V! Rv3806c!
EMB! ubiA# BOVAFRI! 4269351! 483! G/A! 161! GCC/GCT! A/A! Rv3806c!
EMB! aftA# 1.2.2! 4238120! 189! G/A! 63! CAG/CAA! Q/Q! Rv3792!
EMB! aftA# 4.1.2.1! 4239298! 1367! C/T! 456! GCC/GTC! A/V! Rv3792!
EMB! aftA# 4.4! 4238963! 1032! C/T! 344! CAC/CAT! H/H! Rv3792!
EMB! aftA# 5! 4239843! 1912! A/C! 638! AAG/CAG! K/Q! Rv3792!
EMB! aftA# 7! 4238778! 847! G/A! 283! GTG/ATG! V/M! Rv3792!
EMB! nuoD# 2.1! 3513538! 201! A/T! 67! GAA/GAT! E/D! Rv3148!
EMB! nuoD# 4.3.4.2! 3514512! 1175! G/C! 392! GGT/GCT! G/A! Rv3148!
RMP! rpoB# 3! 762434! 2628! T/G! 876! GGT/GGG! G/G! Rv0667!
RMP! rpoB# 4! 763031! 3225! T/C! 1075! GCT/GCC! A/A! Rv0667!
RMP! rpoC# 1! 763884! 515! C/T! 172! GCC/GTC! A/V! Rv0668!
RMP! rpoC# 1! 763886! 517! C/A! 173! CGG/AGG! R/R! Rv0668!
RMP! rpoC# 1.1! 765171! 1802! C/T! 601! CCG/CTG! P/L! Rv0668!
RMP! rpoC# 1.1.3! 765230! 1861! G/A! 621! GCG/ACG! A/T! Rv0668!
RMP! rpoC# 4.1! 765150! 1781! G/A! 594! GGG/GA
G!
G/E! Rv0668!
RMP! rpoC# 4.3! 764995! 1626! C/G! 542! GCC/GCG! A/A! Rv0668!
RMP! rpoC# 7! 764013! 644! A/C! 215! GAG/GCG! E/A! Rv0668!
RMP! rpoC# 7! 766955! 3586! G/A! 1196! GAG/AAG! E/K! Rv0668!
STR! rrs# 4.3.2! 1472337! 9! C/T! 9!! 9!! 9!! 9!!
STR! gid# 1! 4407873! 330! C/A! 110! GTG/GTT! V/V! Rv3919c!
STR! gid# 1.1.3! 4407780! 423! C/T! 141! GCG/GCA! A/A! Rv3919c!
STR! gid# 2.2! 4407927! 276! T/G! 92! GAA/GAC! E/D! Rv3919c!
STR! gid# 4! 4407588! 615! T/C! 205! GCA/GCG! A/A! Rv3919c!





coordinate!on! the!H37Rv! reference!NC_000962.3! (**).!The!alternative!allele! (right!hand!nucleotide! in!
column! four)! is! the! one! specific! to! the! lineage! or! sub9lineage,! with! the! exception! of! two! cases! (**),!
lineage!4!and!4.9,! in!which! the! reference!allele! is! the!one!specific! to! the! lineage.!SNPs!are!annotated!








FLQ! gyrA# 1! 8452! 1151! C/T! 384! GCA/GTA! A/V! Rv0006!
FLQ! gyrA# 1.2.1! 9260! 1959! G/C! 653! CTG/CTC! L/L! Rv0006!
FLQ! gyrA# 3.1.2.2! 9611! 2310! C/T! 770! GAC/GAT! D/D! Rv0006!
FLQ! gyrA# 4.3.3! 8040! 739! G/A! 247! GGC/AGC! G/S! Rv0006!
FLQ! gyrA# 4.5! 7892! 591! G/A! 197! CTG/CTA! L/L! Rv0006!
FLQ! gyrA# 4.6.1! 7539*! 238! A/G! 80! ACC/GCC! T/A! Rv0006!
FLQ! gyrA# 5! 9566! 2265! C/T! 755! TAC/TAT! Y/Y! Rv0006!
FLQ! gyrA# 7! 8876! 1575! C/T! 525! TAC/TAT! Y/Y! Rv0006!
FLQ! gyrB# 1! 6112! 873! G/C! 291! ATG/ATC! M/I! Rv0005!
FLQ! gyrB# 1.1.2! 6124! 885! C/T! 295! GCC/GCT! A/A! Rv0005!
FLQ! gyrB# 4.3.2.1! 5520! 281! C/T! 94! CCG/CTG! P/L! Rv0005!
FLQ! gyrB# 4.3.2.1! 7222! 1983! C/T! 661! AGC/AGT! S/S! Rv0005!
PZA! rpsA# 2! 1834177*! 636! A/C! 212! CGA/CGC! R/R! Rv1630!
PZA! rpsA# 7! 1834916! 1375! A/C! 459! ACC/CCC! T/P! Rv1630!
ETH! ethA# 1.2.2! 4326439! 1035! G/T! 345! AAC/AAA! N/K! Rv3854c!
ETH! ethA# 3.1.2.2! 4326176! 1298! T/G! 433! GAG/GCG! E/A! Rv3854c!
ETH! ethA# 4.6.2.2! 4326739! 735! G/C! 245! CGC/CGG! R/R! Rv3854c!
ETH! ethR# 4.6.2.2! 4328004! 456! G/A! 152! GTG/GTA! V/V! Rv3855!
ETH! inhA# 6! 1674434! 233! T/C! 78! GTG/GCG! V/A! Rv1484!
AMI! rrs# 4.3.2! 1472337! 9! C/T! 9! 9! 9!! 9!!
AMI! gid# 1! 4407873*! 330! C/A! 110! GTG/GTT! V/V! Rv3919c!
AMI! gid# 1.1.3! 4407780! 423! C/T! 141! GCG/GCA! A/A! Rv3919c!
AMI! gid# 2.2! 4407927*! 276! T/G! 92! GAA/GAC! E/D! Rv3919c!
AMI! gid# 4! 4407588*! 615! T/C! 205! GCA/GCG! A/A! Rv3919c!
AMI! gid# 4.3! 4408156*! 47! A/C! 16! CTT/CGT! L/R! Rv3919c!
CAP! rrs# 4.3.2! 1472337! 9! C/T! 9! 9! 9! 9!
KAN! rrs# 4.3.2! 1472337! 9! C/T! 9! 9! 9! 9!
AMK! rrs# 4.3.2! 1472337! 9! C/T! 9! 9! 9! 9!





Epitope!Id! Start! End! Locus!Id! Amino!acid!sequence! Lineage_SNP!
7000006195549910! 157070! 157129! Rv0129c! AAVGLSMSGGSALILAAYYP! 3_157129!
7000006195549960! 2952682! 2952741! Rv2626c! DDDRLHGMLTDRDIVIKGLA! 7_2952738!
7000006195549960! 2952712! 2952771! Rv2626c! DRDIVIKGLAAGLDPNTATA! 7_2952738!
7000006195549960! 2955088! 2955147! Rv2628! IRAVGPYAWAGRCGRIGRWG! 7_2955128!
7000006195549970! 2955358! 2955417! Rv2628! DWPAAYAIGEHLSVEIAVAV! 7_2955392!
7000006195549970! 2955058! 2955117! Rv2628! MSTQRPRHSGIRAVGPYAWA! 4.8_2955061!
7000006195549970! 2955118! 2955177! Rv2628! GRCGRIGRWGVHQEAMMNLA! 7_2955128!
7000006195549980! 1403228! 1403287! Rv1255c! RRARWVVRMLTSLLMFPGRD! 5_1403266!
7000006195550000! 3079639! 3079698! Rv2770c! VANRALLAELTATNILGQNV! 1.1.1.1_3079685!
7000006195550000! 3079669! 3079728! Rv2770c! TATNILGQNVSAIAATEARY! 1.1.1.1_3079685!
7000006195550000! 3079819! 3079878! Rv2770c! SHITNPAGLAHQAAAVGQAG! 4_3079877!
7000006195550020! 2955058! 2955102! Rv2628! MSTQRPRHSGIRAVG! 4.8_2955061!
7000006195550020! 2955088! 2955132! Rv2628! IRAVGPYAWAGRCGR! 7_2955128!
7000006195550020! 2955103! 2955147! Rv2628! PYAWAGRCGRIGRWG! 7_2955128!
7000006195550020! 2955118! 2955162! Rv2628! GRCGRIGRWGVHQEA! 7_2955128!
7000006195550040! 2955358! 2955402! Rv2628! DWPAAYAIGEHLSVE! 7_2955392!
7000006195550040! 2955373! 2955417! Rv2628! YAIGEHLSVEIAVAV! 7_2955392!
7000006195549590! 4352424! 4352468! Rv3874! AQAAVVRFQEAANKQ! 7_4352439!
7000006195549590! 4352439! 4352483! Rv3874! VRFQEAANKQKQELD! 4.1.2.1_4352475!
7_4352439!
7000006195549590! 4352454! 4352498! Rv3874! AANKQKQELDEISTN! 4.1.2.1_4352475!
7000006195549590! 4352469! 4352513! Rv3874! KQELDEISTNIRQAG! 4.1.2.1_4352475!
7000006195549600! 686965! 687012! Rv0589! VAFRAGLVMEAGSKVT! 4.9_686972!
7000006195549610! 4351141! 4351194! Rv3873! PMLAAAAGWQTLSAALDA! 4.1.2.1_4351160!
7000006195549620! 4351723! 4351776! Rv3873! GPMQQLTQPLQQVTSLFS! 1_4351759!
7000006195549620! 4351753! 4351806! Rv3873! QQVTSLFSQVGGTGGGNP! 1_4351759!
7000006195549640! 352028! 352081! Rv0288! AMEDLVRAYHAMSSTHEA! 6_352058!
7000006195549640! 352058! 352111! Rv0288! AMSSTHEANTMAMMARDT! 6_352058!
7000006195549640! 3378771! 3378830! Rv3019c! YAGTLQSLGADIASEQAVLS! 1_3378828!
7000006195549640! 3378801! 3378860! Rv3019c! DIASEQAVLSSAWQGDTGIT! 1_3378828!
7000006195549650! 3378921! 3378980! Rv3019c! SMSGTHESNTMAMLARDGAE! 7_3378952!
7000006195549650! 3378951! 3378998! Rv3019c! MAMLARDGAEAAKWGG! 7_3378952!
7000006195549670! 4352418! 4352462! Rv3874! TAAQAAVVRFQEAAN! 7_4352439!
7000006195549670! 4352430! 4352474! Rv3874! AAVVRFQEAANKQKQ! 7_4352439!
7000006195549670! 4352442! 4352486! Rv3874! RFQEAANKQKQELDE! 4.1.2.1_4352475!
7000006195549670! 4352466! 4352510! Rv3874! QKQELDEISTNIRQA! 4.1.2.1_4352475!
7000006195549690! 4352424! 4352483! Rv3874! AQAAVVRFQEAANKQKQELD! 4.1.2.1_4352475!
7_4352439!
7000006195549690! 4352454! 4352513! Rv3874! AANKQKQELDEISTNIRQAG! 4.1.2.1_4352475!
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epitope.!
 
7000006195549730! 1020433! 1020477! Rv0915c! LGQNSAAIAATQAEY! 5_1020452!
7000006195549780! 4352409! 4352483! Rv3874! AAGTAAQAAVVRFQEAANKQKQELD! 4.1.2.1_4352475!
7_4352439!
7000006195549780! 4352454! 4352528! Rv3874! AANKQKQELDEISTNIRQAGVQYSR! 4.1.2.1_4352475!
7000006195549790! 3187480! 3187554! Rv2875! GASVTVTGQGNSLKVGNADVVCGGV! 4.3.1_3187535!
7000006195549790! 3187525! 3187599! Rv2875! GNADVVCGGVSTANATVYMIDSVLM! 4.3.1_3187535!
7000006195549810! 4357092! 4357151! Rv3878! AAELAPRVVATVPQLVQLAP! 4.1_4357123!
7000006195549820! 4266002! 4266061! Rv3804c! FYSDWYQPACGKAGCQTYKW! 4.4.1.2_4266036!
7000006195549820! 4266032! 4266091! Rv3804c! GKAGCQTYKWETFLTSELPG! 4.4.1.2_4266036!
7000006195549850! 4265981! 4266040! Rv3804c! PVGGQSSFYSDWYQPACGKA! 4.4.1.2_4266036!
7000006195549850! 4266011! 4266070! Rv3804c! DWYQPACGKAGCQTYKWETF! 4.4.1.2_4266036!
7000006195549570! 2227288! 2227359! Rv1983! NGIVTAPTAVNVVLLSIPTSPFAI! 7_2227339!
7000006195549570! 3351437! 3351508! Rv2994! PSWGLVVTMFAWGYLLDHVGERMV! 1_3351472!


















































ERR036233! 477777777673771! Orphan! 82! 1,!1.1,!1.1.2,!4.3,!4.3.4,!4.3.4.1!
ERR036248! 777777777700371! T! 108! 4,!4.3.4,!4.3.4.2.1,!4.8!
ERR037469! 777777777473771! Manu1! 351! 1,!1.2.2,!4.3,!4.3.4,!4.3.4.2,!4.3.4.2.1!
ERR161049! 777777606060771! LAM119ZWE! 69! 2.2.1,!4,!4.3,!4.3.4,!4.3.4.2,!4.3.4.2.1!
ERR161050! 000000200003771! Orphan! 53! 2,!2.2,!2.2.1,!4.3,!4.3.4,!4.3.4.2,!
4.3.4.2.1!
ERR161071! 713777753003771! Orphan! 154! 3,!BOV9AFRI!
ERR161077! 721777746413771! Orphan! 72! 1,!1.1,!1.1.3,!4.1,!4.1.1,!4.1.1.3!
ERR161078! 773777777773771! Orphan! 69! 1,!1.1,!1.1.3,!4.1,!4.1.1,!4.1.1.3!
ERR161123! 757777737450031! Orphan! 89! 1,!1.2.2,!4.3,!4.3.4.2,!4.3.4.2.1!
ERR163947! 404077777413771! Orphan! 57! 1,!1.1,!1.1.2,!1.2.2!
ERR164021! 777777777473771! Manu1! 188! 1,!1.2.2,!4.3,!4.3.4,!4.3.4.2,!4.3.4.2.1!
ERR176549! 000000004060731! Orphan! 62! 4,!4.2,!4.3,!4.3.4,!4.3.4.2,!4.3.4.2.1,!
4.6.1,!4.6.2.1,!4.6.2.2!
ERR176611! 000000000003771! Beijing! 68! 2,!2.2,!2.2.1,!4.3.4.2!
ERR176616! 777777606060771! LAM119ZWE! 60! 1,!1.1,!1.1.3,!4.3,!4.3.4,!4.3.4.2,!
4.3.4.2.1!
ERR176620! 777764207360771! Orphan! 60! 4,!4.3,!4.3.3,!4.3.4,!4.3.4.2,!4.3.4.2.1!
ERR176652! 700777746003371! Orphan! 40! 1,!1.1,!1.1.3,!4.3.4!
ERR176653! 700076777360771! Orphan! 50! 4,!4.1,!4.1.1,!4.1.1.3,!4.3,!4.3.4.2.1!
ERR176661! 477477777410571! Orphan! 47! 1,!1.1,!1.1.2,!4.6!
ERR176709! 503377400041771! Orphan! 53! 3,!3.1.1,!4.3,!4.3.4,!4.3.4.2,!4.3.4.2.1!
ERR181686! 777777606060771! LAM119ZWE! 79! 3.1.1,!4.3,!4.3.4,!4.3.4.2,!4.3.4.2.1!
ERR181705! 777777616462671! Orphan! 108! 1,!1.2.2,!4,!4.3,!4.3.4,!4.3.4.2,!
4.3.4.2.1!
ERR181782! 703377404001771! Orphan! 130! 3,!3.1.1,!4.1.1!
ERR181811! 700777747433771! Orphan! 52! 1,!1.1,!1.1.3,!4.1,!4.1.2,!4.1.2.1!
ERR181813! 777777706473771! Orphan! 66! 1,!1.1,!1.1.3,!4.3,!4.3.4,!4.3.4.2,!
4.3.4.2.1!
ERR181974! 777777606060771! LAM119ZWE! 66! 4,!4.3,!4.3.4,!4.3.4.2,!4.3.4.2.1,!
4.6.1.1!
ERR181977! 477740017453731! Orphan! 90! 1,!1.1,!1.1.2,!4.1.2!
ERR182003! 000000007760771! Orphan! 89! 4,!4.3,!4.3.3,!4.9!
ERR182015! 777777775760731! T2! 71! 4,!4.3,!4.6,!4.6.1,!4.6.1.2!




ERR182041! 637774777760730! T29Uganda! 73! 4,!4.3.4.2,!4.6,!4.6.1,!4.6.1.1!
ERR190343! 703777740003771! CAS19Delhi! 93! 3,!4.3,!4.3.4,!4.3.4.2.1!




ERR212005! 727377404001771! Orphan! 59! 3,!3.1.1,!4.3,!4.3.4!
ERR212098! 000036500003771! Orphan! 134! 1,!2,!2.2,!2.2.1!
ERR216914! 777753777760671! Orphan! 50! 4,!4.3,!4.3.4,!4.3.4.2,!4.3.4.2.1,!4.4,!
4.4.1,!4.4.1.2!
ERR221561! 777777607760731! LAM4! 58! 4,!4.3,!4.3.3,!4.3.4,!4.3.4.2!
ERR221567! 700777747413771! EAI69BGD1! 63! 1,!1.1,!1.1.3,!4.3.4.2.1!
ERR245754! 777777777763771! Manu2! 200! 2,!2.2,!2.2.1,!4.1,!4.1.2!
ERR245795! 777377407761771! Orphan! 132! 3,!3.1.1,!4.3,!4.3.2,!4.3.2.1!
ERR245797! 677777607760771! LAM1! 175! 4,!4.3,!4.3.4,!4.3.4.1,!4.3.4.2,!
4.3.4.2.1!











































Rv0682! rpsL! 2.66E940! information!pathways! 30S!ribosomal!protein!S12!RpsL!
Rv3919c! gid! 2.55E939! cell!wall!and!cell!processes!
Probable!glucose9inhibited!
division!protein!B!Gid!
Rv1816! 9! 2.91E934! regulatory!proteins!
Possible!transcriptional!
regulatory!protein!












rrs! rrs! 7.08E929! stable!RNAs! Ribosomal!RNA!16S!
Rv3069! 9! 6.15E927! cell!wall!and!cell!processes!
Probable!conserved!
transmembrane!protein!































Rv0671! lpqP! 4.77E914! cell!wall!and!cell!processes!
Possible!conserved!lipoprotein!
LpqP!
Rv3746c! PE34! 7.76E912! PE/PPE! Probable!PE!family!protein!PE34!(PE!family9related!protein)!

























































Rv0682! rpsL! 5.83E951! information!pathways! 30S!ribosomal!protein!S12!RpsL!





Rv1816! 9! 5.67E931! regulatory!proteins!
Possible!transcriptional!
regulatory!protein!






























Rv2000! 9! 9.14E926! conserved!hypotheticals! Unknown!protein!









Rv3792! aftA! 1.82E925! cell!wall!and!cell!processes!
Arabinofuranosyltransferase!
AftA!


































































Rv0365c! 9! 9.55E906! conserved!hypotheticals! Conserved!protein!





















































































Rv0682! rpsL! 1.55E916! information!pathways! 30S!ribosomal!protein!S12!RpsL!






Rv3476c! 9! 4.51E915! 9! 9!
Rv1816! 9! 1.57E914! regulatory!proteins!
Possible!transcriptional!
regulatory!protein!
Rv1452c! PE!PGRS28! 1.59E914! PE/PPE! PE9PGRS!family!protein!PE!PGRS28!










Rv3347c! PPE55! 0.000495! PE/PPE! PPE!family!protein!PPE55!
Rv1091! PE!PGRS22! 0.001347! PE/PPE! PE9PGRS!family!protein!PE!PGRS22!







Rv0578c! PE!PGRS7! 0.001877! PE/PPE! PE9PGRS!family!protein!PE!PGRS7!
Rv2736c! recX! 0.004461! information!pathways! Regulatory!protein!RecX!
Rv2490c! PE!PGRS43! 0.004543! PE/PPE! PE9PGRS!family!protein!PE!PGRS43!
Rv0104! 9! 0.007272! conserved!hypotheticals! Conserved!hypothetical!protein!
Rv2059! 9! 0.008331! conserved!hypotheticals! Conserved!hypothetical!protein!
STR/A!
Rv0682! rpsL! 4.68E937! information!pathways! 30S!ribosomal!protein!S12!RpsL!





















Rv2202c9 Rv2203! 2.77E925! cell!wall!and!cell! Possible!conserved!membrane!
206 
 
Rv2203! promoter! processes! protein!






Rv0143c! 9! 2.87E923! cell!wall!and!cell!processes!
Probable!conserved!
transmembrane!protein!
Rv1816! 9! 3.16E922! regulatory!proteins!
Possible!transcriptional!
regulatory!protein!































! Rv1148c! 9! 1.82E918! insertion!seqs!and!phages! Conserved!hypothetical!protein!
STR/B!






















































Rv1816! 9! 9.05E935! regulatory!proteins!
Possible!transcriptional!
regulatory!protein!






























Rv0682! rpsL! 1.95E925! information!pathways! 30S!ribosomal!protein!S12!RpsL!
Rv0143c! 9! 4.58E925! cell!wall!and!cell!processes!
Probable!conserved!
transmembrane!protein!
Rv2000! 9! 6.80E925! conserved!hypotheticals! Unknown!protein!
ETH/B!
Rv1816! 9! 0.000557! regulatory!proteins!
Possible!transcriptional!
regulatory!protein!































Rv1873! 9! 0.01181! 9! 9!












































































Rv3069! 9! 3.48E905! cell!wall!and!cell!processes!
Probable!conserved!
transmembrane!protein!










Rv1663! pks17! 0.021396! lipid!metabolism!
Probable!polyketide!synthase!
Pks17!
Rv2799! 9! 0.021931! cell!wall!and!cell!processes! Probable!membrane!protein!
209 
 





















Rv1830! 9! 0.035624! conserved!hypotheticals! Conserved!hypothetical!protein!
Rv3428c! 9! 0.038173! insertion!seqs!and!phages! Possible!transposase!




rrs! rrs! 7.65E917! stable!RNAs! Ribosomal!RNA!16S!






Rv2181! 9! 1.60E911! cell!wall!and!cell!processes!
Alpha(19
>2)mannosyltransferase!




















































Rv2181! 9! 2.44E905! cell!wall!and!cell!processes!
Alpha(19
>2)mannosyltransferase!











































































































































Rv1816! 9! 0.000171! regulatory!proteins!
Possible!transcriptional!
regulatory!protein!
Rv0235c! 9! 0.00018! cell!wall!and!cell!processes!
Probable!conserved!
transmembrane!protein!
























































Rv3067! 9! 9.19E906! conserved!hypotheticals! Conserved!hypothetical!protein!
Rv3899c! 9! 9.75E906! conserved!hypotheticals! Conserved!hypothetical!protein!
Rv3189! 9! 1.59E905! conserved!hypotheticals! Conserved!hypothetical!protein!
























































































































































































































































































































Supplementary! Figure! 3!Global! phylogeny! of! 1,601!MTBC! isolates! colour,! coded! by!
spoligotype!
!


























(Filliol! et# al.! 2006)! yielded! an! incompatible! classification! compared! to! that! obtained! by! Comas93!











A!global!phylogeny! (WGS!data! set!2;!n=1,601!samples)! constructed!using! the!93! lineage9specific!SNPs!
proposed!by!(Comas!et#al.!2009)!shows!all!6!MTBC!main!lineages!and!M.#bovis!unambiguously!separated!
in!different!clades.!Samples!from!sub9lineage!2.1!(non9Beijing),!2.2!(Beijing),!4.3!(LAM),!4.1.1!(X9family),!









Global! phylogeny! constructed! (WGS! data! set! 2;! n=1,601! samples)! using! the! 71! phylogenetically!
informative!SNPs!proposed!by!(Homolka!2012).!The!phylogeny!is!largely!congruent!with!that!built!using!
Comas93! SNP! set,! all! main! seven! MTBC! lineages! are! clearly! separated.! Samples! belonging! to! sub9
lineages!4.2.1!(Ural),!4.2.2.1!(TUR),!4.3!(LAM),!4.4.1.1!(S9type),!4.1.2.1!(Haarlem)!and!4.6.2.2!(Cameroon)!











Summary!of!DR9associated!genes!and!mutations! in! the!curated! library! for! INH!(296!variable!sites,!350!
SNPs!and!25!indels,!in!4!genes!and!3!promoters)!and!mutations!observed!in!phenotypically!INH!resistant!
samples.!Colour9coded!bars!in!the!Circos!plot!represent!genes!described!to!be!involved!in!DR.!On!top!of!
each!of! these!bars! a! grey!histogram!shows! the!mutation!density!derived! from! the! curated! list!of!DR9
associated!mutations.! These! grey! areas! highlight! the! presence! of! DR9associated! regions! in! candidate!









Summary!of!DR9associated!genes!and!mutations! in! the!curated! library! for!RMP! (97!variable!sites,!143!


















each!of! these!bars! a! grey!histogram!shows! the!mutation!density!derived! from! the! curated! list!of!DR9
associated!mutations.! These! grey! areas! highlight! the! presence! of! DR9associated! regions! in! candidate!









Summary!of!DR9associated!genes!and!mutations! in!the!curated! library! for!PZA! (225!variable!sites,!280!
SNPs!and!64!indels,!in!2!genes!and!1!promoter)!and!mutations!observed!in!phenotypically!PZA!resistant!
samples.!Colour9coded!bars!in!the!Circos!plot!represent!genes!described!to!be!involved!in!DR.!On!top!of!
each!of! these!bars! a! grey!histogram!shows! the!mutation!density!derived! from! the! curated! list!of!DR9
associated!mutations.! These! grey! areas! highlight! the! presence! of! DR9associated! regions! in! candidate!












Summary! of! DR9associated! genes! and!mutations! in! the! curated! library! for! STR! (35! variable! sites,! 44!
SNPs,!in!2!genes)!and!mutations!observed!in!phenotypically!STR!resistant!samples.!Colour9coded!bars!in!
the! Circos! plot! represent! genes! described! to! be! involved! in! DR.!On! top! of! each! of! these! bars! a! grey!
histogram!shows!the!mutation!density!derived!from!the!curated!list!of!DR9associated!mutations.!These!
grey! areas! highlight! the! presence! of! DR9associated! regions! in! candidate! genes.! Vertical! black! lines!
indicate!the!frequency!of!mutations!observed! in!phenotypically!resistance! isolates.! Internal!black! lines!








and! 5! indels,! in! 3! genes! and! 1! promoter)! and! mutations! observed! in! phenotypically! ETH! resistant!
samples.!Colour9coded!bars!in!the!Circos!plot!represent!genes!described!to!be!involved!in!DR.!On!top!of!
each!of! these!bars! a! grey!histogram!shows! the!mutation!density!derived! from! the! curated! list!of!DR9
associated!mutations.! These! grey! areas! highlight! the! presence! of! DR9associated! regions! in! candidate!










Summary! of! DR9associated! genes! and!mutations! in! the! curated! library! for! FLQ! (38! variable! sites,! 52!
SNPs,!2!genes)!and!mutations!observed! in!phenotypically!FLQ!resistant! samples.!Colour9coded!bars! in!
the! Circos! plot! represent! genes! described! to! be! involved! in! DR.!On! top! of! each! of! these! bars! a! grey!
histogram!shows!the!mutation!density!derived!from!the!curated!list!of!DR9associated!mutations.!These!
grey! areas! highlight! the! presence! of! DR9associated! regions! in! candidate! genes.! Vertical! black! lines!
indicate!the!frequency!of!mutations!observed! in!phenotypically!resistance! isolates.! Internal!black! lines!














Circos! plot! represent! genes! described! to! be! involved! in! DR.! On! top! of! each! of! these! bars! a! grey!
histogram!shows!the!mutation!density!derived!from!the!curated!list!of!DR9associated!mutations.!These!
grey! areas! highlight! the! presence! of! DR9associated! regions! in! candidate! genes.! Vertical! black! lines!
indicate!the!frequency!of!mutations!observed! in!phenotypically!resistance! isolates.! Internal!black! lines!











and! 10! indels,! in! 2! genes)! and!mutations! observed! in! phenotypically! CAP! resistant! samples.! Colour9
coded!bars! in!the!Circos!plot!represent!genes!described!to!be! involved! in!DR.!On!top!of!each!of!these!
bars! a! grey! histogram! shows! the! mutation! density! derived! from! the! curated! list! of! DR9associated!
mutations.!These!grey!areas!highlight!the!presence!of!DR9associated!regions!in!candidate!genes.!Vertical!











Summary! of! DR9associated! genes! and!mutations! in! the! curated! library! for! KAN! (12! variable! sites,! 14!






































































































































































































for! each!drug,!both!within!each!population!and!overall.! The!point! estimates! are! represented!by! solid!
rectangles! with! size! proportional! to! the! population! size,! where! horizontal! lines! represent! the! 95%!
confidence!intervals.!The!overall!estimate!is!represented!by!a!diamond!with!width!representing!the!95%!
confidence!interval.!Dotted!vertical!lines!are!drawn!at!the!overall!estimates.!The!data!presented!in!this!
supplementary!figure!correspond!to!that!of!Table!4.2.!  
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